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Ring the bells that still can ring 
Forget your perfect offering 
There is a crack, a crack in everything 
That is how the light gets in 
 
Leonard Cohen, Anthem 
 

  
ABSTRACT 
Background Sex differentiation depends on a complex set of molecular events. These are at one point initiated 
by SRY gene expression and involve gene transcription, which in turn can be affected by the prescence or 
absence of different co-factors, availability of and exposure to sex hormones, presence and sensitivity of steroid 
receptors that directs growth and development. DSD conditions represent variations in typical sex differentiation 
with discordance between sex chromosomes, gonads, hormones or genital appearance. Both mechanisms 
underlying sex differentiation of body, brain, behavior and psychological outcome in many DSD conditions 
remain understudied. 
 
Aim To increase knowledge of outcome in DSD patient groups regarding psychosocial and psychological 
parameters and contribute to the knowledge on biological factors with impact on sex differences in cognition and 
gender role behavior. 
 
Study I  
Methods Psychosocial outcome in men and women with congenital adrenal hyperplasia (CAH) (n=588) was 
assessed through registry studies with regards to education, income and participation in work life, dependency on 
social welfare, marriage and fertility. Patients were compared to controls from the general population matched 
for age, sex and place of living. 
Results Individuals with CAH had less often completed primary education (OR=0.5), had more periods on sick 
leave (OR=1.7) and had children less often than controls (OR=0.3). Women with CAH were married less often 
(OR=0.2) and men were married more often than controls (OR=0.4). Women with SW had income in the top 
20% more often (OR=2.0) and both men and women with SW had disability pension more often (OR=2.8). 
 
Study II  
Methods Psychiatric morbidity in women with complete androgen insensitivity (CAIS) (n=20), gonadal 
dysgenesis (GD) (n=13) and premature ovarian insufficiency (POI) (n=21) was assessed through a structured 
diagnostic interview (MINI-V) and self-report questions, and compared to age matched controls from the 
population. 
Results Psychiatric morbidity was increased for women with CAIS and GD compared with controls from the 
general population (p=.003) but not in comparison to women with POI. Depression (p=.03) and anxiety disorder 
diagnoses (p=.003) were increased with an overrepresentation of obsessive compulsive disorder diagnoses 
(p<.001). 
 
Study III and IV  
Methods Cognitive abilities in women with CAIS (n=18), XYGD (n=6) and XXGD (n=7) and men with 
hypospadias (n=89) were assessed using a battery of cognitive tasks that typically yield sex differences and were 
compared to age matched controls.  
Results The cognitive test battery revealed sex differences in the expected directions. Women with CAIS or 
XYGD performed more similar to female than male controls except on the test of emotion recognition and word 
fluency where they had lower performance. Women with XXGD outperformed all other groups on the emotion 
recognition task. There were no differences between men with hypospadias and male controls neither on the 
cognitive test battery nor the retrospective gender role behavior questions.  Men with proximal hypospadias 
performed slightly lower overall than men with distal hypospadias. 
 
Conclusions Psychosocial and psychiatric outcome is impaired in women with DSD and in some aspects for 
men with CAH. Results from the cognitive study in women with DSD support theories of androgen influence on 
cognitive abilities but factors related to karyotype may influence emotion recognition. Further studies are 
warranted particularly regarding mechanisms behind superior performance of women with XXGD on emotion 
recognition and general cognitive abilities in men with proximal hypospadias. 
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LIST OF DEFINITIONS 
 
Aneuploidy - the presence of an abnormal number of chromosomes in a cell. 
 
DSD - congenital conditions where chromosomal, gonadal, or anatomical sex is atypical. 
 
Gender - the psychological experience of being male or female, in between, both or other.  
 
Gender role - behaviors, preferences and traits that differ between males or females in a given 
culture and historical period. 
 
Gender identity - the core sense of the self as male, female or other  
 
Genotype - the genetic make up of an individual, for example a description of the gene and 
type of mutation  
 
Haploinsufficiency - when only a single functional copy of a gene pair is present and the 
resulting phenotype is characterized by loss of function of this gene.  
 
Heterozygous - the genomic state in which one of two copies of a gene is present. 
 
Homozygous - the genomic state in which two copies of a gene is present. 
 
Intersex - previously used term for DSD conditions in medical settings and literature. 
Presently used in settings other than medical to refer to DSD.  
 
Karyotype - the number and appearance of chromosomes in the nucleus of a eukaryotic cell, 
is also used to refer to the test that detects this complement or measures the number. 
 
Nuclear receptor - a class of proteins in cells that are sensitive to steroids and together with 
other proteins up regulate the expression of specific genes controlling the development, 
homeostasis and metabolism of the organism.  
 
Phenotype - an individual’s set of observable characteristics or traits. 
 
QOL - Quality of life  “an individuals perception of their position in life in context of the 
culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns.” - Quality of life group, WHO 
 
Sex - the categories male, female or other based on physical or biological attributes such as 
sex chromosomes, gonads, internal or external reproductive structures. 
Sexual orientation - the direction of romantic and sexual attractions to males, females both or 
other/neither. 
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1 INTRODUCTION 
 
Sex and gender are important defining factors in society at large and on an individual level. 
The debate over the existence, magnitude and importance of sex differences and similarities 
is a somewhat eternal question that is discussed in many parts of academia and elsewhere. 
Despite this, there are still large knowledge gaps concerning the mechanisms, impact and 
significance of sex differences and debate over their origins and the relative contributions of 
nature and nurture. The knowledge field struggles with difficulties of teasing apart biological 
and social processes often acting in concert creating interactional effects, resulting in rich 
variation and a spectrum of outcomes.  
Disorders or differences of sex development, DSD incorporates a vast number of conditions 
where somatic sex is atypical with regards to sex chromosomes, hormonal situation, gonads 
and/or genital anatomy. The spectrum includes a variety of conditions that can affect gender 
and identity development, growth, fertility and general health. Diagnoses in the spectrum 
range from benign variations to conditions requiring life long medication and medical 
interventions.  
Much of what is known concerning biological sex differences and sex development in 
humans has been clarified through learning about underlying reasons for DSD conditions and 
the psychological and somatic development in patients with these conditons. Yet, the 
outcome and main mediators of psychosocial and psychosexual outcome in individuals with 
many of these rare conditions remains unknown and are understudied. Small patient groups 
and other methodological limitations hamper studies that have the potential to increase the 
understanding of biological contributions to sex differences. Lately, improved techniques in 
gene sequencing have made possible more precise genetic diagnostics and subdivision of 
diagnoses that were previously based on phenotype only. This, together with development of 
new research paradigms in experimental research has revealed an intricate interplay between 
specific genes and co-factors in interaction with endocrine systems that steer development 
along the molecular pathways towards sex differentiation with quite some variation within 
and between species. 
 
1.1 SOMATIC SEX DEVELOPMENT AND DIFFERENTIATION. 
Sex differentiation refers to the biological development steering the individual in either a 
male or a female direction. The nomenclature and theory concerning the mechanisms behind 
sex differentiation is developed through a vast amount of experimental animal research. 
Through translational research and clinical studies this theory is applied and constitute the 
basic framework for describing sexual differentiation in humans as well.  
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1.1.1 Sex determination, sex differentiation of genitals 
The development of genitalia in a male or female direction is a fairly short but well directed 
growth period, steered by parallel activating and inhibitory factors, interacting in a precise 
temporal pattern. It begins early in life around the third week of gestation. The first phase is 
referred to as sex determination, a function of specific genes located on the sex chromosomes 
that will initiate and in most cases determine the direction of further development (1). 
Although sex chromosome aneuploidy occurs quite frequently, between 1/400 – 1/1000 
births (2,3), sometimes resulting in sex chromosome complement of X only, men typically 
have XY chromosomes while the majority of women have XX chromosomes. In the first five 
weeks of fetal development, embryos have undifferentiated internal structures that later 
develop into internal and external genitals. The structures that will form the inner genitalia for 
male development are referred to as Wolffian ducts and the female structures as Müllerian 
ducts. Individuals of both sexes have bipotential gonads that can develop towards either 
ovaries or testes.  
When the first determining events have occurred, subsequent sex typical development is 
referred to as sex differentiation (1). Many genes important for sex differentiation and as 
such, significant in the understanding of the etiology of DSD conditions, have been mapped 
out (4). Mutations in different genes may have different effect depending on karyotype and 
presence of other factors. For example a dysfunction in SF-1, a nuclear transcription factor 
important for gonadal formation, may cause premature ovarian insufficiency (POI) in 46,XX 
individuals, dysgenetic or absent testes in a 46,XY individual and may cause adrenal 
insufficiency in both (5).  
Male 
The development of male genitalia precedes that of female development and begins in the 
third week of gestation when testis development is initiated. The sex determining region of 
the Y chromosome, the SRY gene is at present described as the dividing agent that initiates 
male development by directing the bipotential gonad towards testes (6). It promotes 
expression of genes that activates and maintains the male gonadal differentiation pathway 
with differentiation of the cells into Sertoli and Leydig cells. The Leydig cells of the testes 
will secrete testosterone, which will drive further development and promote survival of the 
Wolffian ducts. The Sertoli cells will secrete anti-Müllerian hormone, which will induce 
regression of the Müllerian ducts (7).  
In week five the cloacal folds form on the cloacal membrane and fuse to become a structure 
labeled the genital tubercle (GT) with the labioscrotal folds developing on either side of this 
structure. The distal part of the GT will subsequently elongate and differentiate into the penis 
while the labioscrotal folds fuse to form the scrotum. This is to a large part an androgen 
driven process. Testosterone (T) from the Leydig cells of the testes is converted in peripheral 
tissues into the more potent androgen; dihydrotestosterone (DHT) by the enzyme 5α-
reductase. This enzyme is present in different concentrations in peripheral tissues, therefore 
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acting locally. The Wolffian ducts grow into vas deferens, the seminal vesicle and epididymis 
of the male inner genitalia. This development is typically finished by the 20th gestational 
week. Finally, the testicular hormone, insulin like factor-3 promotes the descent of the testes 
through the abdomen and testosterone facilitates their descent into the scrotum. This is 
generally completed by the 32th gestational week (1,8). Later in life, androgens (particularly 
testosterone) contribute to the development of secondary sex characteristic in puberty such as 
beard growth, lowered voice and increased bone and muscle mass. (9) 
Female 
In females the Y bound gene SRY is not present. As a consequence, ovary specific 
transcription factors and genes will initiate and maintain the development of the 
undifferentiated gonad into an ovary. No equivalent gene of SRY has been identified for ovary 
formation. The Müllerian ducts will persist and develop into oviducts, uterus, and the upper 
part of the vagina. The Wolffian ducts will degenerate and the genital tubercle will form a 
clitoris and the labioscrotal folds the labia. The lower part of the vagina is formed from the 
sinovagal bulb (1,4). Estrogens are the sex hormones produced by the ovaries. They are 
primarily responsible for the secondary sex differentiation of females particularly during 
pubertal development. Adrenal androgens induce secondary sex characteristics such as hair 
growth. 
Several singular genes have been identified as important for the etiology of DSD conditions. 
Both genetic variant, expression of genes, and deficiencies of enzyme production or function 
can cause deviations from the path of typical sexual differentiation. Important aspects have 
been identified in terms of gene dosage effects, the temporal aspect, cofactor and 
transcription factor function. Variations in this development create the spectrum of DSD 
conditions (4,8,10).  
 
1.1.2 Concepts in theory of sex development 
Masculinization refers to development of typically male features as in the retention and 
development of the Wolffian structures or the changes that will promote the expression of 
typically male sexual behavior in adulthood. Feminization refers to the processes by which 
typically female development will take place. Defeminization is the term used for the 
development leading the individual towards development of a masculine phenotype. The 
degeneration of the Müllerian ducts is one such example. The logically derived term 
demasculinization has fewer applications. It can sometimes denote the disruption of a 
masculinizing process but since many masculinizing effects are more or less irreversible, the 
term is seldom used (11). In variations of genital development, virilization is sometimes used 
to describe growth in the male direction in females and undermasculinization is used to 
describe, “arrested development” in males. 
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1.1.3 Determinants and driving forces of sex differentiation 
Sex chromosomes 
Both men and women inherit an X chromosome from their mother. Women also inherit 
another X chromosome from their father while men inherit a Y chromosome from their 
father. The X chromosome carries around 900 genes, many of which are important for brain 
development (12). In individuals with more than one X chromosome gene dose equivalence 
is kept in balance by a mechanism referred to as X-chromosome inactivation (XCI) when a 
significant part of one of the X chromosomes is functionally silenced (13) Either the maternal 
or paternal X can be silenced, with variation in different tissue resulting in mosaicism across 
cell populations. Some genes, around 15%, located on the pseudo autosomal region (PAR) 
escape inactivation (14). 
The Y chromosome carries as few as 80 genes, some of which are known to induce important 
sex differences. Mouse models where the gonadal and the chromosomal sex is decoupled 
(15) have been used to show hormone independent pathways of sex differentiation for 
differences in body size, metabolic disease and cellular tissue differences, independent of 
exposure to sex hormones (16,17).  
Sex steroids 
Sex steroids include hormones like estrogens, androgens and progesterone; signaling 
molecules that steer tissue development and regulate many of the bodys functions and growth 
processes. They are also important actors in somatic sex differentiation.  
 
Fig 1.  Overview of the human steroidogenesis.  
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Steroids are synthesized from cholesterol in the endocrine glands; the testes, ovaries and the 
adrenal glands. Steroidogenesis starts off with cholesterol, which is converted into pregnanes, 
such as progesterones and pregnenolone. From these metabolites, androgens, estrogens and 
the adrenal steroids, the mineralocorticoids and glucocorticoids are synthesized. The process 
of aromatization of androgens into estrogens, takes place throughout the body and in the 
brain. The action and effect of sex steroids are dependent on availability, which in turn 
depends on synthesis, transport, uptake, degradation, as well as prescece of locally converting 
enzymes and functional receptors.     
 
Steroid receptors 
Steroids signal by binding to a group of receptors that are called nuclear receptors. They 
interact with DNA together with co-factors and co-repressors with facilitating or inhibitory 
effects on gene expression. Steroid signaling can also occur on the cell membrane. These 
effects are more rapid and can occur directly in contrast to the more slow progression of 
changes in gene expression (11). 
There is only one known androgen receptor (AR) and it is expressed in both sexes. The gene 
coding for the AR is located on the X-chromosome. The receptor is a protein that binds to 
DNA and induces masculine development (9). Several different androgens can bind to the 
same receptor with effect on different target genes. The sensitivity of the AR receptor can be 
tissue specific (9). For estrogen, at least three different estrogen receptors are described, 
localized in the cell nuclei, cytoplasm and at the cell membrane (18).   
 
1.1.4 Neuroendocrine systems  
The regulation of sex hormones takes place in endocrine systems that often depend on 
feedback mechanisms for homeostatic regulation. The regulation of endocrine processes 
involved in development, reproduction and ageing can be conceptualized and understood 
through a description of the HPG axis i.e., hypothalamic, pituitary, gonadal axis (19). The 
hypothalamus is a structure in the brain located below thalamus and is a part of the limbic 
system. This system links the pituitary gland with the nervous system in the brain by 
secretion of what is sometimes referred to as “neurohormones” (20). This implies that they 
mediate signal between other parts of the brain and the body, which is important for 
endocrine function. The hypothalamus releases GnRH to the pituitary gland, which in turn 
produce LH and FSH. In females these two hormones activate the ovaries that in turn 
produces estrogen and inhibin that regulates the menstrual cycle. Estrogen inhibits the 
production of GnRH by a negative feedback loop to the hypothalamus. In men, LH stimulates 
the testosterone production in the testes, which is crucial for spermatogenesis (20). 
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The HPA axis (hypothalamic-pituitary-adrenal axis) is another neuroendocrine system that 
regulates and is involved in many somatic processes, including stress response, immune 
reactions, digestion, mood and emotion, sexuality and energy storage. The release of 
vasopressin and corticotrophin releasing hormone from the hypothalamus stimulates 
secretion of adrenocorticotrophin (ACTH) from the pituitary gland. This in turn signals to the 
adrenal cortex to produce glucocorticoids, mostly cortisol, a hormone involved in varying 
functions such as glucose metabolism, immune system and stress regulation. Cortisol 
production results in negative feedback to the brain inhibiting both the hypothalamus and the 
pituitary gland (21). 
Activity in these systems has three peaks in human development: early during gestation, post 
partum, also refered to as “minipuberty” and in puberty. Increases in sex typical hormones 
and subsequent decreases induced by feedback mechanisms, create a hormonal milieu that 
directs the individual’s general body growth, the development of genitalia in particular, sex 
characteristics, and also aspects of brain development (22). Further on, pregnancy and 
menopause also constitute periods of considerable systemic change in the hormonal situation. 
 
1.1.5 Models of sex differentiation, organizing effects and critical periods 
Gonadal and adrenal sex steroids exert permanent, sometimes irreversible, sometimes 
transient influences on sex related differences in the brain. Steroids have multiple ways of 
influencing brain development both in terms of structure and function. The underlying 
mechanisms are manifold including altering of cell survival and proliferation, synaptic 
connectivity (11) and cell migration (23) amongst others.  
 
Organizational-activational effects 
Phenomena that occur resulting from changes in levels of sex hormones that have priming or 
lasting effect are traditionally referred to as ”organizational” and assumed to occur during the 
early phases of prenatal or postnatal development but may also occur during puberty. Later, 
the hormonal influences that activate, modulate, or inhibit the effects are referred to as 
”activating” (24,25). Examples of physical changes that are organizing include deepening of 
the voice and feminization such as breast development during puberty. An activational effect, 
i.e. one that can be reversed and depend upon continued stimulation to prevail include male 
body hair dispersion. 
The organizing effects of sex steroids, particularly androgens on brain development have 
been mapped out through experimental studies in animals such as rodents, primates and 
marsupials.  The behaviors investigated are mostly related to sexual behavior as this differs 
considerably between male and female rodents. In primates, other behaviors like play 
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behavior, vocal behaviors and interest in infants have been studied. While qualitative 
differences exist, most behaviors differ primarily in quantity between males and females (26).  
Organizing effects have been shown to induce anatomical differences like the larger volume 
of the sexual dimorphic nucleus of the preoptic area (SDN-POA) and ventromedial 
hypothalamic nucleus (VMN), two regions associated with sexual behavior in male rodents 
(16). Activating effects of circulating androgens can also induce anatomical differences like 
the enlargement of amygdala in male rodents (16). The amygdala is a brain area involved in 
emotion, decision-making and is important in conditioning of responses. This has also been 
observed in humans where brain development during puberty gives rise to anatomical 
differences such as relative size difference before and after in amygdala and hippocampus 
(27). Sex hormone levels, particularly testosterone, has been found to be associated with 
anatomical differences in prefrontal cortex paralleling those of change in executive functions 
in males (28). 
 
Critical periods  
For some effects of sex steroids and their role in genetic events it has been shown that there 
are windows in time where the programmed event occur. If development takes a different 
path, this particular development will not spontaneously be induced later on. One such 
example in humans is male genital development which mainly takes place during the first 
trimester and if arrested or disturbed, will not continue completely after this critical period 
resulting in malformations such as bladder or cloacal extrophy, epispadias or hypospadias.  
In experimental research different models exist to explain the mechanisms behind these 
phenomena. Periodical sensitivity and increasing resistance to sex hormones is one such 
mechanism, (25) epigenetic changes another, (22) to understand periods where development 
accelerates or occur in response to exposure and modulating effects of sex hormones. 
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Figure 2.  Model that shows the organizational/activational hypothesis of brain sex differentiation together with 
suggested rising and declining sensitivity to sex hormones. The line depicts sex steroid exposure, i e the prenatal 
and pubertal surges of testosterone and other gonadal hormones, the yellow blocks correspond to periods during 
gestation, and postnatal potential critical periods and the green curve the window of sensitivity to sex steroids. 
Reprinted from Current topics in behavioural neuroscience, Vol 16, de Vries G., Fields. C., Peters, N., 
Whylings, J. Paul, M., Sensitive Periods for Hormonal Programming of the Brain 286, 79-108, Copyright 
2014, with permission from Springer-Verlag Berlin Heidelberg 
 
1.2 VARIATIONS IN SEX DEVELOPMENT 
Variations in sex development occur spontaneously by mechanisms such as new mutations, 
by inheritance or by environmental disruption of different origin. Individuals whose bodies 
do not match societies expectations of typically male and typically female have always 
existed. The norms of what is considered to be typical bodily features for the two sexes are 
not fixed and can change somewhat between countries and over time, as does the normative 
conception of what signifies masculinity and femininity (29).  
Most babies born are assigned to either sex by assessment of their genitals at birth or by 
ultrasound during gestation. Every year in Sweden, around twenty children are born who 
cannot be assigned to either sex at birth before further investigations, or where there is 
discrepancy between prenatal karyotype test and the appearance of genitalia at birth. When 
this occurs, an investigation is carried out including assessment of karyotype, hormonal 
situation and of internal and external genitalia, specifically gonadal status. A genetic 
screening for known mutations is also made. Based on this information a decision is made as 
to which sex the child will be assigned to grow up in. When making this decision, aspects 
such as need for life long hormone substitution, surgical options, fertility potential and lately, 
also an estimation of prenatal androgen exposure of the brain are taken into account. The aim 
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of the decision is to make a choice that will match gender identity later in life while 
minimizing the need for medical interventions. Sometimes, but not always, a molecular 
diagnosis can be given. 
 
1.2.1 DSD nomenclature 
Since a consensus conference was held in Chicago in 2005, where representatives of patient 
organizations and medical practitioners attended, the nomenclature has been standardized 
with regards to medical terminology with the aim of describing the somatic condition and to 
avoid stigmatizing and imprecise labeling. The categorization is based on sex chromosome 
complement, gonadal status, with diagnoses according to the identified affected gene or 
hormone dysfunction when known (30).  
 
Table 1. Schematic overview of medical classification and nomenclature of DSD conditions 
Sex Chromosome DSD 46,XY DSD 46,XX DSD 
45,X  
Turner syndrome and 
variants 
46,XYGD 
Disorders of gonadal 
(testicular) development  
46,XXGD 
Disorders of gonadal 
(ovarian) development  
46,XXY  
Kleinefelter syndrome 
and variants 
Disorders of androgen 
synthesis or action  
CAIS, 5α-reductase 
deficiency, 17β-HSD 
deficiency 
Androgen excess  
CAH 
45,X/46,XY  
Mixed GD, ovotesticular 
DSD 
Other: genital 
malformations, 
hypospadias 
Other: MRKH 
46,XX/46,XY  
Chimeric, ovotesticular 
DSD 
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1.2.2 Health care in DSD  - historical outlook 
There are early accounts of medical doctors encountering patients with DSD conditions, 
concluding that the person had physical characteristics of the opposite sex post mortem (31). 
Records exist describing interventions concerning the physical sex characteristics as 
corrections of hypospadias among gladiators described by their physician Galen (32).  
The healthcare approach towards DSD in the beginning of the 20th century has been 
described as the ”true sex policy” (33) where the conviction was that if a person’s true sex 
could be determined by some key biological criterion, this would form the basis for sex 
assignment. The role of the gonads in sex differentiation was shown in experiments with 
rabbits (34) and sex hormones, particularly androgens, were identified as key actors in this 
development. The medical discipline of endocrinology has evolved during the first half of the 
20th century, describing the actions and interplay of hormones and their importance for 
physical growth and functioning over all. When karyotype tests became available and 
technical advances made the imaging of internal genitalia possible, the picture became more 
complex. In other parts of healthcare, karyotyping has made for an easy way to “determine 
sex” of children before birth. In the field of DSD, the medical profession could utilize this as 
one of several parameters in the assessments made before sex assignment.  
Around 1950, at Johns Hopkins University clinic, Maryland, USA, a program for gender 
assignment in patients with ambiguous genitalia was developed by the psychologist John 
Money and his colleagues. The policy emerging there, often referred to as the “optimal 
gender policy”, put a priority not only to assigning gender according to genital appearance or 
karyotype, but also took into consideration the preservation of fertility, available hormonal 
and surgical treatments, and the expected sexual function. Based on this, the treatment 
consisted of aligning the physical appearance of genitalia by surgical interventions and/or 
hormonal treatment with the assigned sex. It was believed that gender identity would mainly 
be determined by sex of rearing, thereby emphasizing the importance of being brought up in a 
clear gender role (35).  Knowledge of the condition was considered a risk factor for 
psychosocial adjustment and adult patients today, often describe that they have not been fully 
informed of their condition or that they have had to search for appropriate information 
themselves.  
 
1.2.3 Present day healthcare policies 
There are as of yet no evidence based guidelines for DSD care. Healthcare practices thus vary 
considerably depending on region or type of clinic. The current guideline for care of patients 
with DSD recommends full disclosure of information for the patient and the family. It also 
stresses the importance of working in multidisciplinary teams and puts emphasis on the 
functional outcome of surgery rather than surgery for primary cosmetic reasons (36). This 
paradigm struggles with the same issues as before but also brings new challenges like 
informing parents and children of the basic yet sometimes complex information regarding 
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diagnoses, treatment options and outcome. Whole genome sequencing has brought 
possibilities in terms of precise molecular diagnoses, thereby increasing complexity in terms 
of knowledge of carrier and the implications of inheritance for the individual and other family 
members. Since some of the treatment options used include irreversible hormonal and 
surgical procedures, there is a need for psycho-education in order to support the families and 
individuals in understanding the alternatives at hand to be able to participate more actively in 
decisions concerning the medical management of their condition. DSD healthcare at present 
has been described as being in a state of transition, moving towards a “minimal medical 
interventions” policy (37). 
 
Recent and ongoing changes in treatment practices  
In the last half of the twentieth century many individuals with XY karyotype were assigned 
female sex as the importance of physical appearance on upbringing was emphasized and 
cosmetic surgery was carried out accordingly. The accumulating knowledge of sex 
differentiation of the brain and behavior, acknowledging the role of prenatal exposure to 
androgens for neurobehavioral sex differentiation, has made for a shift in sex assignment 
practices. The assignment of male gender to individuals with XY DSD when they present in 
the newborn period with ambiguous genitalia, if they can be assumed to have had 
considerable amounts of androgen exposure, in utero, has increased (38). The practice of 
surgery in the newborn period is successively being postponed to a period when the patient 
can play a more active part in this process. Surgical techniques are continuously changing and 
as surgery is being delayed, new data is emerging on feasibility of not intervening surgically 
on DSD conditions (39).  
 
1.2.4 The patient perspective 
Discourse around DSD conditions raise questions of its impact on identity development, the 
boundaries of normality and human rights issues. The last couple of years have seen an 
increase in qualitative studies that take the patient perspective and evaluate aspects of living 
with a DSD condition, capturing the more subtle aspects and the subjective experience (40-
44). There are also many patient representatives involved in advocacy and activism to 
educate and create public awareness around these conditions. 
Generally, most advocate groups, activists and non profit organizations that reach out in 
media are propagating for healthcare to be less active in effectuating medical interventions 
and more active in offering psychological support for all affected by these conditions.  
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1.2.5 Characterization of the patient groups included in studies I-IV. 
 
Men and women with congenital adrenal hyperplasia, CAH  
CAH is a group of autosomal recessive disorders of cortisol and aldosterone metabolism. It 
constitutes of a block in one of the five enzymatic steps in the synthesis of cortisol by the 
adrenal glands. The incidence varies in different populations most often between 1/10000 – 
1/15000 (45,46). The most frequent form, referred to as “classic CAH”, affecting more than 
90% of cases, is caused by deficiency of the 21-hydroxylase (21-OH) enzyme that also 
catalyzes the conversion of progesterone to deoxycorticosterone, an aldosterone precursor. 
Aldosterone is a hormone that maintains sodium balance in the body without which salt loss 
and adrenal crisis occurs.  
Untreated CAH can be life threatening; therefore, CAH is included in newborn screening 
programs worldwide. The level of 17-hydroxyprogesterone, the metabolite before the enzyme 
block, is measured within the first days to detect individuals that need treatment to survive. 
The screening programs usually do not identify milder forms of CAH, so called  “non-
classic” forms of the disease, a form where cortisol production is lowered but present and 
symptoms of androgen excess lead to clinical diagnosis, if it is detected at al. Cortisol 
interacts in several of the hormonal axis responsible for basic regulation of sleep, stress, 
immune function, and growth. Symptoms and affected outcome of the disease are manifold 
and might affect several central physiological functions, some visible but most not. There is a 
good correspondence between genotype (CYP21A2 mutation) and clinical manifestations 
such as disease severity (45).  
 
Due to accumulation of precursors and due to HPA axis dysregulation, increased androgen 
levels are present already prenatally. This may lead to varying degrees of virilisation of the 
external genitalia in girls with CAH; fusion of labia and clitoromegaly, while the internal 
genitalia are unaffected. In extreme cases girls can initially be perceived as boys in the 
newborn period, and assigned male sex of rearing (47). The development of boys with 46XY 
and CAH is male typical. Several other physical complications can present in untreated or not 
optimally treated individuals connected with growth, obesity, cardiometabolic riskfactors and 
infertility (48). 
  
Treatment involves lifelong glucocorticoid replacement (hydrocortisone) and 
mineralocorticoid replacement (Florinef). Surgical correction of genitalia in girls with CAH 
used to be carried out in the newborn period but is at present increasingly more often 
postponed due to suboptimal results from surgery follow up studies. Outcome for non-
operated cases shows that a spontaneous reduction in clitoral size occurs after the treatment 
has been initiated and optimized (39).  
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Pubertal development on hydrocortisone treatment is typically female for girls and typically 
male for boys. If compliance problems arise or treatment is not optimal, pubertal 
development can be affected with pseudo-precautious puberty in boys and androgen 
symptoms including amenorrhea in girls. 
 
Women with complete androgen insensitivity, CAIS  
CAIS has an estimated incidence that ranges from 1-5 in 100 000 live births (49,50). The 
condition is due to a mutation in the androgen receptor (AR) gene that causes complete 
insensitivity to androgens. The inheritance is X-linked, recessive meaning that 46,XX 
individuals will be carriers and that the disorder is expressed in 46,XY individuals. 
Individuals with this condition are phenotypically female but have XY chromosomes and 
intra abdominally located testes. Development of typical female internal genitalia is absent 
due to anti-Müllerian hormone (AMH) produced by the Sertoli cells of the testes, and these 
women can therefore not carry a pregnancy. The condition is most often discovered during 
puberty due to primary amenorrhea, at surgery for inguinal hernia, or as the result of prenatal 
karyotype test not matching phenotype at birth. While testosterone does not have any direct 
effect due to the lack of androgen receptor, it is converted to estrogen by aromatisation. 
Therefore, spontaneous pubertal development occurs, including breast development with the 
exception of menarche (51). Due to the lack of androgen effect, body hair is sparse and skin 
complications like acne is absent (52). If vaginal agenesia is present, treatment options vary 
with self-dilation as first choice or more rarely vaginoplasty. 
Treatment consists of estrogen replacement to preserve bone density and promote general 
health. Due to the anticipated risk of germ cell tumour development, gonads were previously 
surgically removed as a standard procedure. Recently, this practice has become questioned 
and gonads are now monitored for malignancies rather than removed (53, 54). These patients 
are known to live in a female gender role and identify as female in terms of gender identity 
(55,56) with few exceptions (57). 
 
Women with XY and XX Gonadal dysgenesis, GD 
Underdeveloped gonads resulting in deficient gonadal steroid production characterize 
gonadal dysgenesis, GD. The condition can be caused by mutations in several genes 
important for gonadal formation (4,58,59).  46, XY GD with complete absence of gonads is 
also referred to as Swyers syndrome (60). In this condition it is common that a uterus and 
fallopian tubes develop, due to lack of AMH although variations exist. With ovum donations 
these women can usually carry a child (61). If dysgenetic gonads exist they are often 
removed due to the risk for malignancies (62). The resulting lack of gonadal hormones has 
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several implications. Infertility and estrogen deficiency are almost always present. The 
condition is sometimes discovered due to primary amenorrhea and absence of secondary sex 
characteristics, which typically implies complete gonadal dysgenesis, CGD. The condition 
can also be partial with low prenatal exposure to androgens. Clinical presentation varies but 
the majority of individuals with complete XYGD are phenotypically female as well as those 
with XXGD (63). Few studies exist regarding gender identity and gender role behavior but 
female identification is described (64). Hormone replacement is often prescribed to preserve 
bone density and promote general health (59).  
 
Women with premature ovarian insufficiency, POI 
POI is clinically manifested as premature depletion of ovarian follicles and onset of 
menopause before the age of 40. Etiologies differ and include genetic, autoimmunity and 
inflammatory processes affecting gonadal function (65). It can be due to enzyme deficiencies, 
metabolic or idiopathic circumstances but can also remain unidentifiable. This leads to 
estrogen deficiency that has wide spread and varying effects on the female body. The women 
are otherwise healthy but receive hormonal substitution in the form of estrogens and cannot 
produce oocytes for own biological children, which is equivalent to the situation for some of 
the women with DSD (66). 
 
Men with hypospadias 
Hypospadias is one of the most common genital malformations with a reported prevalence of 
1/125 newborn boys in Sweden (67). It ranges from mild forms causing mostly cosmetic 
problems with minor displacement of the urethra, to more severe forms with the urethral 
opening at the base of the penis or in the perineum, which may lead to uncertain sex at birth. 
Severe forms can cause problems with sexual function, fertility and in addition, all forms of 
hypospadias can have urinary problems. The etiology is sometimes not known in the 
individual case, causes can be genetic or environmental and are mostly multifactorial (7,68). 
Male genital development is to some extent driven, sustained and supported by testicular 
hormones such as androgens (69), therefore consideration of endocrine factors contribute to 
the understanding of causative mechanisms. Surgery is usually carried out during the first 
year of life. Surgical procedures are sometimes carried out in several steps. If complications 
occur, repeated surgery can be experienced while growing up and in adulthood.  
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1.3 SEX DIFFERENCES; MEASUREMENTS, CONCEPTUALIZATIONS AND 
FINDINGS 
The study of neurobehavioral sex differences takes place in different scientific fields and 
encompasses brain anatomy, basic functions like connectivity and neurotransmission, 
development, cognition and behavior which in turn can be further subdivided into different 
types of behavior on different types of arenas. Social psychology and psychotherapy each has 
research fields devoted to the investigations of sex differences and these fields are probably 
best summed up elsewhere.  
 
Sex – Gender 
The word sex stems from the latin word sexus, the state of being man or woman, which may 
derive from “seco” which refers to -half the race which in turn can be connected to “secare”,    
-to divide (http://www.thesaurus.com). In different research traditions the words sex and 
gender are used but not interchangeably. The ways they are used also to some extent indicate 
the discourse. Sex typically refers to the biological attributes, the differences where biological 
contributions can be discerned or assumed. Gender on the other hand is used to refer to the 
social or cultural roles differing between the sexes and also to describe the experience of the 
individual as being male or female. Early 20th century research concerning gender 
development, which had influence from studies in DSD populations, was using both concepts 
interchangeably. This ceased in the end of the 1970s when scholars were encouraged not to 
refer to sex or biology in an attempt to refrain from determinism in describing gender 
development (70). Since then the academic use of these two concepts have been more distinct 
and separated. 
Since this thesis does not concern the social shaping forces of gendered behavior there will be 
no overview of theories or evidence on the subject included. This should not be interpreted as 
disregarding the importance of these factors that are intertwined with biological effects. No 
biological mechanisms can act independently; we are all born into a social environment and 
become who we are by interaction within a social context throughout life.  
In the literature concerned with biological influences on sex differences, much focus has been 
on investigating the impact of early exposure to sex hormones. Typically the rise in 
testosterone that developing male fetuses are exposed to, that coincides with a critical period 
for development of genitalia, is hypothesized to have an organizing effect. But while sexual 
differentiation and brain development begins and parallels, it does not end at the same time as 
the formation of genitalia during the first trimester. Therefore, in theory, it can be affected 
differently by factors contributing to sex differentiation of other parts of the body (71). 
Contemporary models of the background of sex differences incorporate both biological 
effects in interaction with environmental effects.  
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Fig 3. Biopsychosocial model depicting influences of biology and environment that exert interactive effects. 
This loop can create, increase or reduce sex differences.  
Reprinted from Trends in Cognitive Sciences, Vol 18, Miller D., Halpern. D., (2014) The new science of 
cognitive sex differences 1 37-45, First published in Sex differences in cognitive abilities, Halpern, D. Copyright 
2012 Psychology press, New York, NY  
 
Sex differences in disease 
One of the urgent reasons to study neurobehavioral sex differences is that men and women 
differ in incidence, onset, severity and symptoms in disorders affecting brain development, 
function and aging (16,72). Neuropsychiatric morbidity is more prevalent in boys and men 
(71,73) while mood disorders are overrepresented in women (74,75).  Men and women are 
also differently affected by disorders like schizophrenia (76), Alzheimer’s disease (77,78) 
and Parkinson’s disease (79) both in terms of onset and differences in symptoms. These 
differences in prevalence tend to be large compared to differences in behavior that are 
sometimes modest in magnitude. 
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1.3.1 Sex differences in brain anatomy 
Although a classification of brains as either male or female is a categorization with low 
explanatory value (80) the brains of men and women do in fact differ anatomically. On the 
level of individual cells, each cell contains either of the sex chromosomes of XX, XY or 
other, even though the significance of this difference is not yet clear (81).  
In terms of volume, men’s brains are overall heavier and larger than women’s although this 
difference is smaller, when adjusting for body size (82). When brain size is adjusted for, 
regional differences in size and volume are found such as higher gray matter concentrations 
in women with regional and individual differences (83).  
Although many reasonably large differences have been found in several brain structures, like 
the amygdala, cerebral cortex and the substantia nigra (16), contradicting results are also 
abundant, as reviewed in (27). The measurement method, focus of investigation and 
strategies to adjust for individual brain volumes contribute to inconsistent findings (84).  
While they may be significant, and paralleling sex differences in behavior, anatomical 
differences cannot predict the nature, magnitude and direction of differences in behavior and 
cognition. These factors, therefore have to be studied as an autonomous entity (16). The 
metaphor of computer size and function serves to illustrate this phenomenon.  
 
1.3.2 Sex differences in cognition 
While men and women do not differ on global composite parameters like intelligence tests, 
there are systematic group level differences for particular abilities that while they may vary 
with socioeconomic development and cultural aspects (85), the pattern of differences show 
stability across the globe (86-88) and across the life span (89) in a long term perspective. 
Women are typically superior on verbal abilities (90) and some memory functions (91) while 
men excel on spatial tasks (92,93). Women also have an advantage when reading the 
emotional state in someone’s facial expression (94,95).   
From a developmental perspective, sex differences in children like the discrepancy in verbal 
abilities have been argued to depend to some extent on differences in maturation (96) which 
also provides girls and boys with different periods of developing superior skills. Throughout 
life these differences contribute to differences in choice of education and occupational careers 
(97).  
 
1.3.3 Sex differences in behavior  
Despite overlap in most behaviour, men and women differ systematically in some preferences 
and actions. To describe and conceptualize facets of psychosexual development the terms 
gender role behavior, sexual orientation and gender identity are commonly used.  
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Gender role behavior that is, sex typical behavior, describes the psychological attributes a 
person expresses in daily life that differs between the sexes in a majority of the general 
population. This construct is investigated by different direct and indirect methods. Children’s 
play style, choice of best friend and toy preferences are known to show large sex differences 
with variations during development (98). This can be measured by self-report, parental proxy 
reports or by direct observation. Gender role behavior in adults is often investigated by self 
report questionnaires that inquire about everyday habits, what gender role one thinks others 
regard one as, and other behaviors that are carried out in society and that differs 
systematically between men and women. In some studies, more objective measures are used, 
for example choice of occupation.  
Sexual orientation refers to the direction of a person’s romantic interest, desires and actions. 
This is most often measured by self-report. Homosexual, heterosexual and bisexual are 
concepts most often used in the measurements while literature on sexual orientation also 
include categories like asexual, gynecophilia  or androphilia (35).  
Gender identity (GI) indicates which sex a person self identifies as in the persons own mind. 
GI was defined by John Money as “the private manifestation of gender role” (99) and has 
been defined by Kohlberg as “the cognitive self-categorization as a boy or a girl” (100). 
Other conceptualizations include felt pressure for gender conformity and felt compatibility 
aspects of gender identity (101). A contemporary model put forth by Tobin include five 
dimensions; knowledge of a gender category, gender centrality, gender contentedness, felt 
gendered conformity and gender typicality (102). 
Gender identity development is a dynamic process throughout life with important milestones 
in the preschool years, during puberty and early adulthood (101,103). Traditionally it has 
been measured on a dichotomous spectrum from male to female but at present 
multidimensional assessments also exist.  
These three developmental trajectories do not always correspond and might develop and 
change over time. Likewise variation within groups and a permanent overlap between sexes 
exists for most sex typical behaviors. Psychosexual development is often conceptualized as 
male or female or other. All possible variations cannot be acknowledged in research settings 
or on other arenas, but the individual perception can be unreflected, undecided or nonbinary 
and may well be a situation better described as female and male, ambiguous or in transition.  
There is often a somewhat superficial dichotomous nature introduced by the measurement 
methods in order to make the phenomena under study possible to analyze by quantitative 
statistical methods. For this sake it is worthwhile to emphasize that overlap between the sexes 
and variation within each sex in most aspects studied is greater than the differences between 
them and that predictions about individuals in one category cannot be made on the basis of 
group means (104) .   
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1.3.4 Sex differences related to sex chromosomes – learning from animal 
studies 
For direct, non gonadal effects on sex differentiation of behavior, very little evidence exist in 
humans. The traditional view of gonads and gonadal hormones being the determining agent 
for most biological sex differences was challenged by some classical experiments on zebra 
finch. The male zebra finch sings a special courtship song to his female counterpart. Many 
attempts were made to change this behavior by experimental manipulation of steroid levels 
(105) but failed. Since then, several sex chromosome related effects in different species 
contributing to sex differentiation have been identified (106). These effects can act through 
genes on the Y chromosome either causing masculinizing effects (107) or inhibiting 
feminizing effects.  
The role of sex chromosome complement is investigated in different models. One paradigm is 
the four core genotype, (FCG) mice that includes XY or XX individuals with either testes or 
ovaries or the XY model, varying the number of X and Y chromosomes independently 
(16,108). Type of sex chromosome complement has been shown to be of importance in mice 
models for behaviours such as aggressiveness and parenting behaviour (109), behavioural 
modelling of drug addiction, and social behaviours (17). Hypotheses on mechanisms by 
which these effects arise include non-gonadal effects of Sry or other genes located on the Y 
chromosome (110), X chromosome gene dosage effects and parental imprinting of the X 
gene (15).  Besides more or less direct genetic effects, epigenetic effects can give rise to 
permanent sex differences. This also gives firm evidence for the role of environmental factors 
for the emergence of sex differences in many species (106). 
 
1.4 OUTCOME STUDIES IN DSD POPULATIONS 
 
1.4.1 Cognitive outcome studies in individuals with DSD conditions  
The research field on sex differences in cognitive abilities struggles with issues related to 
interactional effects of biological mechanisms versus those of the environment. Therefore, 
inviting individuals with DSD conditions to participate in research is one possible mode to 
study biological sex differentiation, as sex chromosomal disposition, hormonal situation and 
sex of rearing sometimes may be decoupled.  
Individuals with Turner (45,X DSD) and Klinefelter (47,XXY DSD) syndrome often have 
cognitive dysfunction, which is a common finding in groups of individuals with sex 
chromosome aneuploidy (Hong 2014). It is therefore difficult to draw conclusions even 
though many outcome studies regarding cognitive abilities exist (111-114).  
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CAH 
Most of what is known concerning early androgen exposure effects on cognition is learned 
through studies in women with CAH. The results concerning effects on spatial ability are 
mixed with some reporting no effect (115-118), or no effects for mental rotation tasks but 
targeting (119), while others report enhanced spatial ability (120,121,122). Taken together, 
higher spatial performance in comparison with control girls was supported in a meta study 
(123). Disease severity moderates the effect (124) and biomarkers for prolonged exposure for 
androgens correlates with improved performance in a computerized water maze task (125). In 
contrast, boys with CAH have been found to have normal or impaired spatial abilities (119-
121).  
CAIS 
There are few studies exploring cognitive functions in patients with CAIS. The first two  
(126,127), compared women to their relatives, on tests measuring general intelligence. 
Women with CAIS performed inferior to controls (127) on tests of visuo-spatial ability, but 
not overall intellectually or verbally (126). The largest study investigating spatial cognition 
with fMRI in CAIS (n21) failed to detect a difference in performance between patients and 
female or male controls, although differences in activation where noted, with men having 
increased activation in the inferior parietal regions. The activation pattern of women with 
CAIS resembled those of control women more than men, thereby indicating a role for 
hormonal influences rather than chromosomal effects on brain activation patterns (128). 
Another study (n=11) of performance on a virtual analogue of the water maze task showed 
that women with CAIS performed intermediary between men and women (129). To our 
knowledge there are no previous studies in individuals with hypospadias or complete gonadal 
dysgenesis on cognitive functions. 
 
1.4.2 Psychosexual outcome in DSD 
Many studies in DSD patient groups investigating psychological endpoints in DSD patient 
groups have focused on psychosexual development, posing research questions pertaining to 
the biological shaping forces of sex differences (130). In conditions characterized by 
androgen excess, such as CAH, it has been shown that girls and women more often prefer 
activities and interests in male dominated areas (131) and choose more male dominated 
occupations as adults (132,133) and that there is an overrepresentation of women with sexual 
orientation other than heterosexual (134,135). This is associated with the higher than usual 
prenatal exposure to androgens that also has effect on play style. Girls with CAH play more 
similar to boys (136) with a dose response effect, operationalized as disease severity (137).  
A study that included measurement of socialization showed no crucial role for socialization 
on psychosexual development in girls with CAH, although some evidence supports 
individual variation in terms of the size of the role for different influencing factors (138).  
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In the majority of individuals with conditions characterized by deficiencies in androgen 
function or synthesis, such as CAIS and Complete GD, gender role and gender identity 
development is typically female (56,59). In DSD conditions, where individuals with XY sex 
chromosomes and partial or typical androgen function is present, the picture is more varied 
(139,140). Men with hypospadias are typically reported to develop and live in a male gender 
role (141-143). In many DSD conditions, sex of rearing is still the best predictor of gender 
identity (101,144).  
 
1.4.3 Psychosocial outcome in DSD populations 
Studies investigating mental health issues in DSD present varying outcomes. Investigations 
of quality of life (QoL) have revealed acceptable QoL for groups with a mixture of diagnoses 
when assessed by generic QoL instruments in comparison to the rest of the population (145-
147) and to control group (40,148). When wellbeing is assessed by more multifaceted or 
sensitive approaches, impaired outcome is reported with respects to psychiatric symptoms, 
wellbeing and relationships (149), fatigue, attention and memory problems as well as 
emotional and behavioral problems (150).  
Essential to outcome in DSD is also the outcome of genital surgeries. Body satisfaction and 
sexual wellbeing is varied and often affected, particularly in conditions where early surgical 
interventions have been performed. The scope of investigations of psychosexual outcome in 
DSD cohorts with clinical objectives is sometimes not limited to the individual’s wellbeing. It 
also has the objective to assess outcome of practices surrounding sex assignment and early 
treatments. The majority of individuals with DSD are generally content with their sex of 
rearing (151) but in comparison to the general populations there is a slight increase in the 
frequency of gender dysphoria (152) and gender transitions (144) which is sometimes 
difficult to predict based on information from the clinical diagnosis (153,154).  
 
CAH 
The few studies investigating mental health issues in children with CAH show increased 
prevalence of ADHD, particularly for boys, and increased prevalence of anxiety disorders 
(155). Self rated QoL for children with CAH differ slightly from the proxyratings by their 
parents (156). The areas affected, as rated by the children, is fatigue, whereas their parents 
state academic underachievement, impaired physical and emotional health and psychosocial 
outcomes (157). For adults, the outcome results are mixed. Some reports show unaffected 
psychological adjustment measured by self-assessment instruments, (158,159) other report 
impaired QoL and wellbeing (133) for patients with CAH. Health related QoL outcome 
domains that are most often affected is general health and vitality (160). Increased prevalence 
of psychiatric morbidity is present for both men (161) and women, particularly regarding 
anxiety, depression and substance abuse (162). Compared to other chronic conditions, QoL 
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investigations have showed better outcome than for patients with diabetes (163) or adrenal 
insufficiency (164). For males with CAH, QoL has been less often assessed but found to be 
acceptable, with differences between groups with different treatment strategies. Factors 
shown to affect QoL and psychosocial outcome are type of glucocorticoid therapy (165,166), 
suboptimal surgery outcome (167,168) and trauma from investigations in childhood (169).   
Sexual function for women with CAH is associated to surgical outcome and is often 
negatively affected (133,168), particularly in severe genotype groups (170).  Patients own 
perceptions of surgical outcome is not always assessed but have been shown to differ 
somewhat from clinicians (171).  
The prevalence of gender dysphoria has been assessed in girls and women with CAH 
showing mixed results. Studies show consistently that a majority of girls or women with 
CAH experience a core female identity (172) but may still have experienced that they  
”…wanted to be of the opposite sex” (134). Gender identity issues are prevalent also in 
individuals with 46,XX karyotype and CAH raised as males although these results must be 
treated with caution since there is a scarcity of studies (172,47). With respect to recalled 
childhood gendered play behavior, sexual preferences, and core gender identity, 46,XY boys 
with CAH did not differ from other boys (134,173). Most women with CAH report 
heterosexual orientation but between 10-50% report other than heterosexual orientation 
(135), compared to around 2.5 % in the Swedish population (133). 
Qualitative studies in groups of women with CAH focus on the impact of the condition on 
relationships, sexuality, gender identity, gender role and healthcare experiences. Negative 
impact of the condition vary, but includes suboptimal outcome of surgery, and problems in 
forming relationships (42,44). 
Patients report isolation and embarrassment over information concerning the condition as 
well as discomfort with aspects of the medical treatment, anxiety about sexual contacts and 
impaired body image (41).  
 
CAIS 
There are a few reports on psychosocial wellbeing and QoL in CAIS, but outcomes are 
contradictory, possibly because of small patient numbers and participation bias (174). Some 
studies indicate better outcome compared to other individuals with DSD diagnoses (116) or 
unaffected compared to controls (56). An Italian study in a larger cohort reported good 
psychosocial adjustment, superior academic achievement and QoL, while at the same time 
higher frequency of psychological distress such as depression, anxiety, internalizing and 
externalizing symptoms. 
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The few reports of gender identity/gender role behavior from populations of CAIS 
individuals show female identification and female gender role behavior (175), although 
singular cases of gender dysphoria have been reported (57).  
Qualitative studies of women with CAIS report distress related to infertility, deviation from 
norms around female, low self esteem and fear of devaluation on the basis of having CAIS 
(176). A German follow up study of eleven participants with CAIS described difficulties 
coping with the disorder and its psychological consequences and others report high 
percentages that had utilized psychological care or support of some kind (57). Typically, 
most of the women with CAIS receive the diagnosis in the teenage years. This experience is 
described as traumatic while reactions and coping abilities have been shown to depend partly 
on life experiences before receiving the diagnoses (43).  
 
Hypospadias 
Many studies of psychosocial outcome in hypospadias show acceptable QoL (142) despite 
some indications of adverse outcomes like dissatisfaction with sexual wellbeing and negative 
penile perception post surgery (177,178). A large cohort study based on registry data showed 
that in most psychosocial outcome parameters studied (education level, income level, and 
marriage), men with hypospadias did not differ from controls (67). They did however have an 
increased risk of receiving disability pension; this was particularly pronounced in men with 
proximal hypospadias and associated with increase in psychiatric morbidity and 
neurodevelopmental disorders such as autism spectrum disorder (ASD) and intellectual 
disability (67).  
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2 AIM 
The aim of this thesis is to increase knowledge on outcome in DSD patient groups with 
regards to psychosocial outcome, psychiatric comorbidity, cognitive abilities and gender role 
behavior. Furthermore it discusses the contribution of biological factors to sex differences in 
cognition and gender role behavior. 
 
2.1 RESEARCH QUESTIONS  
• Does psychosocial outcome for men and women with CAH differ from population 
controls? (Study I) 
• Are there sex differences and does disease severity moderate psychosocial outcome for 
men and women with CAH? (Study I) 
• What is the prevalence of psychiatric morbidity in women with CAIS, GD, POI?(Study II)  
• Are there differences between women with congenital or acquired hormone dysfunction in 
the prevalence of psychiatric morbidity? (Study II) 
• Do factors related to variation in sex chromosomes and/or androgen function affect 
performance on cognitive tasks that typically yield sex differences? (study III)  
• Does selfreported gender role behavior and performance on cognitive tasks that typically 
yield sex differences differ between men with and without hypospadias or between men 
with different severity of hypospadias? (study IV) 
 
 
2.2 DESCRIPTION OF THE PROJECT   
These studies are part of a larger follow-up program of adult patients with DSD in Sweden 
including a clinical retrospective follow-up,  a prospective study of children assessed for sex 
assignment in the new born period and registry studies of patient cohorts.  
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3 OVERVIEW OF STUDY I-IV 
 
3.1 STUDY I   
Suboptimal psychosocial outcomes in patients with CAH.  
 
3.1.1 Background  
This is a matched case cohort study comparing the existing and historical cohort of CAH 
patients in Sweden to a matched control group from the general Swedish population 
investigating psychosocial outcome. Measures were chosen in order to replicate previous 
research findings from other countries on psychosocial outcome parameters and to reflect 
areas of daily life of importance for quality of life.  
 
3.1.2 Methods 
Setting 
The study was conducted in collaboration with the institute of medical epidemiology and 
biostatistics (MEB) at Karolinska Institutet.  
 
Data sources - registers 
All patients with a confirmed CYP21A2 deficiency born from 1910 and onward are included 
in the national CAH register (46) held by the newborn screening laboratory in the Centre for 
Inherited Metabolic Diseases CMMS, Karolinska Hospital.  The national patient register 
(NPR) contains information on patient, geographical, administrative and medical data from 
inpatient care at public hospitals. The register is updated once a month from each of the 
county councils in Sweden. The register used to contain data on inpatient care only, but 
incorporates outpatient visits for surgery and psychiatric care since 2001. Primary care is not 
yet covered in the NPR. It was used in study I to identify patients not included in the national 
registry which had the diagnosis of CAH. The total population register contains information 
on births, civil status, citizenship, migration and place of residence. It is held by Statistics 
Sweden. The multi-generations register contains information on relationships between people 
born after 1932 and their parents/adoptive parents. Both were used in study I to identify 
controls, assess marital status and the number of children of patients. Longitudinal 
integration database for health and labor market studies, (LISA) is a database containing 
information on income, education, employment, and data from the social insurance agency. 
Data is available from 1990 and onward. This database was the main sources of outcome data 
in study I.  The education register contains further information on education from 1985 and 
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onward and was used in study I to assess eligibility for higher education for the part of the 
cohort born after 1989. 
 
Study population 
Women and men with congenital adrenal hyperplasia (CAH)  
CAH patients (n=588) either included in the national CAH registry (46) (n=545) or detected 
through the National Patient registry (n=43) constitute the study group.  
The patients identified through the national patient registry were those that had been given 
the diagnosis of CAH (ICD-8: 255.01, 255.08; ICD-9: 2552, 255C; ICD-10: E25.0) on more 
than two occasions and that had no other endocrine diagnoses (i.e. Cushings syndrome, 
acromegaly) or malignancies requiring glucocorticoid treatment.   
 
All patients with a confirmed CYP21A2 deficiency, born between 1910-2009, were included. 
The patients were matched for sex, year and place of birth with 100 controls per patients from 
the general population. The patients’ identities were anonymized before linkage in registries 
and analyses were performed on the cohort as a whole and on subgroups based on clinical 
severity (salt wasting SW, simple virilising SV, non classic NC) and type of mutation. This 
classification of genotype group was made depending on the severity of the mildest CYP21A2 
allele. The classification in groups of clinical severity was made either by that predicted by 
genotype or by the authors (AN, HF) through medical information.  
 
 
Table 2. Classification of clinical severity based on genotype and number of participants in each genotype 
group. NR= identified in national registry only. NPR=identified in national patient registry only. 
SW n=240 SV n=167 NC n=75 Unknown n=106 
Null n=100 I172N n=130 V281L n=56 NR n= 63 
I2splice n=122 P30L n=24  NPR n=43 
Clinical n=18 Clinical n=13 Clinical n=19   
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Table 3. Outcome measures for psychosocial outcome 
Measures 
Complete 
education 
Eligibility for secondary education (LISA) 1 
Primary 
education 
To have basic education as the highest level of education. 
Higher 
education 
To have attained education after primary education. 
Working 3-7 
years 
To have been employed more than 3, less than 7 years consecutively. 
Working >7 
years 
To have been employed for more than 7 years consecutively. 
High income Disposable family income in the top 80th percentile. 
Low income Disposable family income below the 20th percentile. Income was including 
earned income and allowances. 
Sick leave To have had sick leave periods (longer than 14 consecutive days) during a 
period of two years. 
Disability 
pension 
To ever have received compensation in the form of early retirement given to 
those not able to participate in the open labor market (LISA). 
Social welfare Dependency on social welfare for anyone in the family for more than one 
year (LISA). 
Marriage The first registered marriage or partnership (Multigenerations register). 
Children Whether one had biological children, first child. (Multigenerations register). 
1 The eligibility to pursue secondary education change over time and between secondary educations preparatory 
for university or work related programs. Generally it includes having passed in 8-12 subjects, particularly 
Swedish, English and Math. 
 
Statistical methods 
All outcome measures were modeled as dichotomous and a logistic regression was used to 
calculate odds ratios (OR). ORs were calculated with 95% confidence intervals (CI). An OR 
with a CI not surpassing 1 was considered significant. Calculations were performed using 
SAS version 9.3 (Statistical Analyses Systems). 
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3.1.3 Results  
Patients with CAH were less often eligible for secondary education than controls. They had 
more sick leave periods and had received disability pension to a higher degree and were less 
prone to have children than controls. Less women with CAH than controls were eligible for 
secondary education. Men more often had steady employment and also more sick leave 
periods than controls. Both women and men with CAH were less likely to have children than 
controls (table 4).   
Table 4. ORs (CI) for all parameters, comparisons between all individuals with CAH and controls, women with 
CAH and female controls and men with CAH with male controls. 
 All CAH n=588 ♀ n= 335 ♂ n=253 
Complete education 0.5 (0.3-0.9) 0.3 (0.2-0.6) 0.9 (0.4-2.1) 
Primary education 0.8 (0.6-1.1) 0.8 (0.5-1.4) 0.8 (0.5-1.3) 
Higher education 0.7 (0.4-1.2) 0.9 (0.4-1.7) 0.5 (0.2-1.3) 
Working 3-7 yrs 1.3 (0.7-2.2) 1.4 (0.7-2.8) 1.3 (0.5-3.6) 
Working >7 yrs 1.8 (0.99-3.2) 1.6 (0.8-3.2) 3.1 (1.1-8.8) 
High income 0.9 (0.7-1.2) 0.9 (0.7-1.2) 0.8 (0.6-1.2) 
Low income 0.9 (0.6-1.4) 0.8 (0.5-1.4) 1.0 (0.5-2.0) 
Sick leave 1.7 (1.2-2.4) 1.3 (0.8-2.0) 2.8 (1.6-4.8) 
Disability pension 1.5 (1.0-2.2) 1.4 (0.9-2.4) 1.6 (0.8-3.2) 
Social welfare 1.0 (0.7-1.4)  1.1 (0.7-1.7) 0.9 (0.5-1.6) 
Marriage 1.0 (0.8-1.4) 0.7 (0.5-1.0) 1.6 (1.0-2.5) 
Children 0.3 (0.2-0.3) 0.2 (0.1-0.3) 0.4 (0.2-0.6) 
 
Comparisons between individuals with SW CAH and controls 
Patients with SW CAH had received disability pension more often than controls and both 
men and women had less children than controls. Women with SW were less likely to be 
eligible for secondary education but were more likely to have income in the top quintile 
compared to female controls (table 5).  
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Table 5. ORs (CI) for all parameters, comparisons on the level of patient groups subdivided by severity and 
sex between women and men with SW CAH. 
 All SW n=240 SW♀ n=105 SW♂ n=135 
Complete education 1.4 (0.4-5.2) 0.3 (0.1-0.7) 1.2 (0.3-4.6) 
Primary education 1.3 (0.8-2.2) 1.4 (0.7-2.9) 1.2 (0.5-2.5) 
Higher education 0.7 (0.5-1.1) 0.7 (0.4-1.1) 0.9 (0.5-1.7) 
Working 3-7 yrs 0.9 (0.3-2.5) 0.7 (0.2-2.6) 1.4 (0.3-6.7) 
Working >7 yrs 2.3 (0.6-13.6) 2.0 (0.6-6.7) 2.9 (0.6-13.6) 
High income 0.9 (0.5-1.4) 2.0 (1.0-4.2) 1.0 (0.5-1.9) 
Low income 0.9 (0.4-1.9) 1.2 (0.5-3.1) 0.5 (0.1-1.9) 
Sick leave 1.6 (0.9-3.0) 1.6 (0.9-3.0) 1.7 (0.7-4.4) 
Disability pension 2.0 (1.0-3.9) 1.7 (0.7-4.0) 2.2 (0.7-6.9) 
Social welfare 0.8 (0.4-1.4) 0.6 (0.3-1.4) 1.1 (0.4-2.6) 
Marriage 0.9 (0.5-1.5) 0.5 (0.2-1.1) 1.6 (0.7-3.5) 
Children 0.1 (0.1-0.2) 0.05 (0.0-0.1) 0.4 (0.2-0.8) 
 
Table 6. ORs (CI) for all parameters, comparisons on the level of patient groups subdivided by severity and 
sex between women and men with SV CAH. 
 All SV n=167 SV♀ n=91 SV♂ n=76 
Complete education 0.6 (0.2-1.5) 0.3 (0.1-1.1) 1.0 (0.2-4.9) 
Primary education 0.5 (0.2-1.1) 0.5 (0.1-1.6) 0.5 (0.2-1.5) 
Higher education 1.5 (1.0-2.3) 1.4 (0.8-2.4) 1.7 (0.9-3.4) 
Working 3-7 yrs 1.5 (0.5-5.0) 1.7 (0.4-7.5) 1.7 (0.2-15.2) 
Working >7 yrs 1.5 (0.4-5.3) 1.0 (0.2-4.7) 7.3 (0.7-79.8) 
High income 1.3 (0.7-2.2) 1.0 (0.6-2.0) 0.5 (0.2-1.0) 
Low income 0.5 (0.1-1.7) 0.6 (0.1-2.7 0.3 (0.0-2.9) 
Sick leave 2.8 (1.4-5.4) 2.6 (1.1-6.4) 3.4 (1.3-9.4) 
Disability pension 0.8 (0.4-1.9) 0,9 (0.3-2.6) 0.9 (0.2-3.5) 
Social welfare 0.7 (0.3-1.5) 0.7 (0.3-1.8) 0.7 (0.2-3) 
Marriage 1.4 (0.8-2.3) 1.1 (0.6-2.2) 1.8 (0.8-4.4) 
Children 0.4 (0.2-0.7) 0.4 (0.2-0.7) 0.3 (0.2-0.8) 
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Comparisons between individuals with SV CAH and controls 
Both women and men with SV had pursued secondary education more often than controls 
and had more sick leave periods. Both women and men had children less often (table 6).  
 
Comparisons between individuals with NC CAH and controls 
Patients with NC CAH had steady jobs more often and less sick leave periods than controls. 
They were more prone to receive disability pension. Women with NC more often had a 
steady job and were more likely to have received social welfare (table 7). 
Table 7.  ORs (CI) for all parameters, comparisons on the level of patient groups subdivided by severity and sex 
between women and men with NC CAH. 
 All NC n=75 NC♀ n=56 NC♂ n=19 
Complete education 0.5 (0.1-1.9) 0.5 (0.1-2.5) 0.5 (0.0-6.0) 
Primary education 0.6 (0.3-1.2) 0.4 (0.1-1.9) 1.9 (0.2-19.5) 
Higher education 1.8 (0.9-3.5) 1.9 (0.8-4.1) 1.7 (0.4-7.7) 
Working 3-7 yrs 7.6 (1.5-37.4) 6.5 (1.2-35.1) ◊ 
Working >7 yrs 4.5 (0.8-25.4) 3.5 (0.6-20.8) ◊ 
High income 2.1 (0.9-4.9) 2.0 (0.8-5.3) 2.7 (0.3-23) 
Low income 1.0 (0.9-4.9) 1.3 (0.4-4.4) ◊ 
Sick leave 0.3 (0.1-0.7) 0.3 (0.1-1.1) 0.5 (0.1-8.5) 
Disability pension 3.3 (1.0-11.1) 3.4 (0.9-11.8) ◊ 
Social welfare 2.0 (0.9-4.9) 2.4 (1.0-6.2) 1.2 (0.1-10.8) 
Marriage 1.7 (0.7-4.3) 1.4 (0.5-3.9) 3.9 (0.5-32.7) 
Children 0.9 (0.3-2.4) 0.9 (0.3-2.7) 0.9 (0.1-7.1) 
   ◊ ORs cannot be calculated. 
 
3.1.4 Conclusion 
The study showed that the patient group in many aspects did not differ from controls when 
compared on a whole cohort level. When divided by sex and severity, psychosocial outcome 
differed from controls for some groups. Women, particularly those with SW form, were more 
negatively affected in terms of being less often married and not being eligible for secondary 
education while men differed from controls both regarding employment and sick leave. Both 
men and women have decreased fertility.  
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3.2 STUDY II  
Increased psychiatric morbidity in women with complete androgen insensitivity 
syndrome or complete gonadal dysgenesis. 
 
3.2.1 Background  
Previous research on psychosocial and psychological outcome for women with CAIS and GD 
is mixed with some studies indicating minimal impact on psychosocial while at the same time 
larger impact in the form of mental health issues related to the condition. There are few 
previous studies of psychiatric symptomatology in CAIS, GD and POI. The aim of this study 
was to assess the prevalence of psychiatric morbidity in a group of women with CAIS and 
GD and to see whether it differs from that in women with POI. 
 
3.2.2 Methods 
 
Setting 
This study was performed in a clinical setting as a cross-sectional follow-up taking place 
alongside routine annual or bi annual checkups at the department of obstetrics and 
gynecology, Karolinska University hospital. The study was part of a larger project assessing 
medical and mental health, psychosocial and cognitive outcome including gynecological, 
endocrine and anatomical asessments. The patients spent one or two days at the clinic and 
received economic compensation for loss of earnings.  
 
Study population 
The participants were women with CAIS (n=20), complete GD (XYGD n=6, XXGD n=7) 
and women with POI (n =21). 
Women were recruited from all parts of Sweden through their treating physician; the majority 
of the cohort from the department of obstetrics and gynecology, Karolinska University 
Hospital and Uppsala University hospital. The control group (n=61) were matched on age 
and sex with the participating female patients and recruited from the national patient registry 
by letter of invitation (table 8). 
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Table 8. Characteristics of the study population, age, level of education and 
relationship status. 
       Highest level of education 
  Mean age (range) In a relationship Secondary University 
♀ DSD n33 33 (21-57) 21 (64%) 15 (45%) 18 (55%) 
♀ POI n21 21 (21-44) 15 (71%) 9 (43%) 12 (57%) 
♀ Control n61 32 (21-57) 46 (75%) 22 (36%) 38 (62%) 
Subgroups ♀ DSD 
    CAIS n20 34 (21-57) 10 (50%) 11 (55%) 8 (40%) 
46 XY CGD n6 34 (24-47) 3 (50%) 2 (33%) 5 (71%) 
46 XX CGD n7 28 (23-36) 5 (71%) 2 (29%) 4 (67%) 
 
Measurements 
The lifetime prevalence of psychiatric morbidity was assessed using a validated clinical 
interview, the Mini International Neuropsychiatric Interview (MINI+), a structured diagnostic 
interview developed to assess the 17 most common diagnoses in DSM-IV and ICD-10, for 
use as a clinical screening tool or within research settings. This is a frequently used method to 
assess psychiatric morbidity with high sensitivity, specificity and test retest reliability as well 
as acceptable inter-rater reliability (179,180).  
In addition survey questions regarding previous use of psychiatric healthcare and 
psychotropic drug use were analyzed. The questions were part of a larger online survey that 
all patients and controls filled out prior to participation containing questions on educational 
level and marital status. A psychiatrically trained physician or psychologist performed the 
interviews that lasted 15-60 minutes.  
 
Questions regarding utilization of psychiatric healthcare, psychotropic drugs: 
Self reported utilization of healthcare, medication for mental health problems. 
Have you ever been in contact with health care services because of mental health problems?  
Do you take any medication (psychotropic drugs) at the moment?  
Have you ever taken any medication for mental health problems? 
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3.2.3 Results 
 
On the self-report questions, 64% of the women with DSD answered that they had been in 
contact with mental health services compared to 43% among those with POI and 40% of 
controls. 15% of women with DSD were currently on medication as compared to 10% of 
women with POI and 13% of controls. Previous use of medicine was reported for 39% of 
women with DSD, 33% of women with POI and 31% of controls. None of these differences 
were significant. 
Table 9. P-values and odds ratios for differences in psychiatric morbidity for women with DSD (CAIS, XYGD, 
XXGD) and POI and compared to female controls. 
 ♀DSD vs  
♀POI 
♀DSD vs  
♀Controls 
 ♀POI vs 
♀Controls 
 p p OR (CI 95%) p 
At least one psychiatric disorder  0.476 0.003* 5.1 (1.7, 14.9) 0.07 
At least two psychiatric disorders 0.451 0.008* 3.2 (1.3, 7.8) 0.29 
Major depressive episode 0.775 0.030* 2.7 (1.1, 6.5) 0.14 
At least one anxiety disorder 0.403 0.003* 4.2 (1.7, 10.3) 0.16 
Obsessive Compulsive disorder 0.131 <0.000* 21.1 (2.5, 175.3) 0.26 
 
Comparing women with CAIS or GD with, either women with POI, or population controls 
showed that both groups of women with conditions affecting prenatal steroid production or 
sensitivity and the group of women with acquired deficiency of steroid production had 
increased risk for psychiatric morbidity. Among the women with CAIS/GD, 85% fulfilled the 
criteria for one or more psychiatric disorder, which was higher but not significantly so than 
the 76% of women with POI, but significantly more than controls where 54% had at least one 
psychiatric disorder. In both patient groups (CAIS/GD,POI), 67% of women had experienced 
at least one mood disorder and 58% of women with CAIS/GD and 42% of women with POI 
had experienced at least one anxiety disorder (table 9). 
3.2.4 Conclusion  
There is an increased prevalence of psychiatric morbidity in women with CAIS and GD 
especially regarding anxiety disorders. Due to this, increased attention to the presence of 
mental health issues is warranted in the care for all women with DSD and POI. The basic care 
of DSD women should include a screening for psychiatric symptoms and also include an 
offer for psychological support.  
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3.3 STUDY III  
Cognitive abilities in complete androgen insensitivity, CAIS or gonadal 
dysgenesis, GD  
 
3.3.1 Background 
Many questions remain unanswered regarding mechanisms behind sex differences in 
cognitive abilities. Prevailing theories concerning biological contributions to these differences 
in performance and/or ability focus on early and prolonged exposure to sex hormones. There 
is however evidence of direct effects of sex chromosomes on sex typical behavior in other 
domains and in other species. This is a research area where interaction between effects of 
socialization, and different biological contributions challenge research design. Including 
individuals with DSD as subjects is one way to investigate biological contributions to sex 
differences.  
3.3.2 Methods 
 
Setting 
The subjects were recruited and assessed in the same cross-sectional follow up setting as 
study II, alongside the annual or biannual checkup.  
 
Study population 
The participants were women with CAIS (n=18) or XYGD (n=6) or XXGD (n=7). Women 
were recruited from all parts of Sweden through their treating physician; the majority of the 
cohort was from the department of obstetrics and gynecology, Karolinska University Hospital 
and Uppsala University Hospital. The control groups were matched on age (day of birth) and 
sex, recruited from the national patient registry by letter of invitation. The female controls 
were matched with the women with CAIS, CGD while the men were matched with a cohort 
of men with hypospadias, the participants in study IV. In the female control group from the 
general population many women turned out to be nonnative Swedish speakers. To 
compensate for this some additional female controls (n=18) in the same age range were 
recruited from groups of students and administrators at KI and Stockholm University.  
The female controls completed the assessment at a clinic visit, except for those recruited at a 
later point in time. Most of the men in the male control group participated online, from home.  
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Measurements 
The outcome parameter was performance on cognitive tasks that typically yield sex 
differences. A battery of online tests was constructed for this study. The tasks were chosen 
because they had previously been shown to yield group level sex differences in studies 
performed in the general population (181). The tasks in which men often perform at a higher 
level than women were mental rotation task (182) and a version of the judgment of line angle 
task, (183). The tasks where women typically outperform men were verbal fluency (FAS), 
episodic memory with faces as stimuli (91) and an emotion recognition task “The Reading 
the Mind in the Eye” test (184). A vocabulary test (SRB) was included typically not yielding 
sex differences and was used to indicate level of verbal ability in the different groups. The 
tests were adapted for online use with minor adjustments and Swedish instructions. 
Statistical analysis 
When analyzing performance on tests where language proficiency could affect results, all 
controls born abroad were excluded from the analysis. Comparisons with regards to 
differences in performance were made with one-way ANOVA with group (CAIS/XYGD, 
female controls, male controls) as fixed factor. The women with CAIS and XY were 
combined into one group as they were assumed to have similar exposure to androgens and 
sex chromosome complement. In order to explore differences between patient groups for 
hypothesis generating purposes, a one-way ANOVA with group (XYGD, XXGD, CAIS) as 
fixed factor was computed. When the effect of group was significant, Tukey post hoc tests 
were computed. All analyses were two tailed, with alpha set to <.05. 
3.3.3 Results 
Table 10. P-values for comparisons between female and male controls, women with CAIS or XYGD and 
between patient groups women with CAIS, XYGD and XXGD on all tasks. 
 Vocabulary Spatial 
direction 
Mental 
rotation 
Episodic 
memory 
Word 
fluency 
Typing 
speed 
Emotion 
recognition 
♀ controls vs ♂ controls 0.03* 0.00** 0.00** 0.02* 0.00** 0.65 0.02* 
CAIS/XYGD vs ♀ 
Controls 
0.74 1.00 0.99 1.00 0.03* 0.92 0.02* 
CAIS/XYGD vs ♂ 
Controls 
0.49 0.01* 0.01* 0.16 0.28 0.98 0.68 
Patient groups contrasts        
CAIS vs XYGD 0.90 0.73 0.69 0.97 0.04* 0.80 0.59 
CAIS vs XXGD 0.99 0.97 0.69 0.39 0.09 0.34 0.00** 
XYGD vs XXGD 0.95 0.69 1.00 0.68 0.36 0.27 0.00** 
Note(a) Typing was included as a covariate when analyzing differences in word fluency performance 
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All women and men in the control groups differed on all tasks except typing speed. Women 
with CAIS and XYGD underperformed relative to female controls on the emotion 
recognition and verbal fluency task. Women with CAIS and XYGD underperformed relative 
to the male control group on the spatial direction and mental rotation tasks. In the 
comparisons between patient groups, women with CAIS underperformed relative to women 
with XYGD on the word fluency task and there was a trend in the same direction relative to 
women with XXGD. Finally women with XXGD outperformed both women with CAIS and 
XYGD on the emotion recognition task (table 10).  
 
3.3.4 Conclusion 
The results support theories of androgen influence on cognitive abilities as women with 
dysfunction in androgen sensitivity or production perform lower than male controls and on 
the same level as female controls. There are also indications of effects more directly linked to 
sex chromosomes on variation in emotion recognition performance as women with 
CAIS/XYGD perform on the same level as male controls. The superior performance of 
women with XXGD could also be related to their special hormonal and chromosomal 
situation, but due to the small participant numbers this needs to be replicated before 
conclusions can be drawn. The conclusions hitherto do not exclude the possibility of parallel 
effects of socializing processes. 
 
3.4 STUDY IV  
No difference in cognitive performance or gender role behavior between men with 
and without hypospadias 
 
3.4.1 Background 
Hypospadias is a common genital malformation of different severity, affecting 1/125 boys 
born in Sweden yearly. The incidence has been reported to be increasing, etiology is 
multifactorial and the exact cause is often not known. Since male genital development is 
dependent on androgen action the question has been raised of whether hypospadias is also 
associated with variations in psychosexual outcome or if other aspects of development are 
affected. The few previous studies investigating gender role behavior in hypospadias have 
been inconclusive indicating increase of cross-gendered behavior (185) or no differences 
(141). There were no previous studies of cognitive abilities in boys or men with hypospadias. 
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3.4.2 Methods 
Setting 
A cohort of men with hypospadias (n=83), who were operated on at Karolinska when they 
were children, who lived in and around the Stockholm area, and had agreed to participate in 
the larger cross sectional follow up study (178) were invited to participate in cognitive 
assessment. The majority of men with proximal form of hypospadias participated in cognitive 
testing as part of an outpatient clinic visit. All the men with distal hypospadias, and all 
controls were offered the possibility to participate online. 
 
Patients and controls 
Men with hypospadias of different severity participated. The majority had distal form (n=73) 
and a small group of men had proximal hypospadias (n=10). A female control-group (the 
same as in study III) was included to ensure the validity of the cognitive tests and gender role 
questions. 
 
Measurements 
The cognitive battery of tests accessible online were the same as in study III.  Participants 
also completed a web survey containing instruments measuring psychosocial outcome such 
as questions inquiring about childhood gender role behavior. These questions were used to 
assess childhood toy and activity preferences and sex of best friend in childhood, in 
adolescence or in adulthood.  
 
Statistical analysis 
Comparisons with regards to differences in performance on the cognitive tests were made 
with one-way ANOVA with group (female controls, male controls, men with hypospadias) as 
fixed factor. In order to explore differences between patient groups based on severity, for 
hypothesis generating purposes, a one-way ANOVA with group (men with distal 
hypospadias/men with proximal hypospadias) as fixed factor was computed. When the effect 
of group was significant, Tukey post hoc tests were computed. All analyses were two tailed, 
with alpha set to <.05. When analyzing performance on tests where language proficiency 
could affect results, all patients and controls born abroad were excluded from the analysis. 
 
Comparisons with regards to self reported gender role behaviour were not expected to be 
normally distributed, therefore nonparametric statistical methods were applied: The Kruskal-
Wallis test to compare the three groups (female controls/ male controls/ men with 
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hypospadias) and a Mann-Whitney U test for post hoc comparisons of significant results. For 
comparison between men with distal (n=73) and proximal hypospadias (n=10) Mann-
Whitney U test was used. 
 
3.4.3 Results  
Background factors such as age and education were equal between the different groups. Both 
the cognitive tests and the questions on gender role behavior showed sex differences between 
the male and female control group in the expected directions. No significant differences were 
found between men with hypospadias and men in the control groups neither on the cognitive 
tasks, nor on self reported gender role behavior in childhood. Men with proximal hypospadias 
performed generally lower on the cognitive tasks, exept for on the emotion recognition task. 
This reached significance only on the test of episodic memory (p=.031) and word fluency 
(p=0.038). 
 
3.4.4 Conclusion 
Hypospadias in general is not associated with differences in performance on cognitive tests 
that typically yield sex differences, or with altered gender role behaviour in childhood. This 
indicates that the disturbance of genital growth occurring in the prenatal period, a possible 
sensitive period for brain development when sex differentiation of brain anatomy and 
function takes place, is not reflected in adult life in terms of differences in cognitive abilities 
or recalled childhood gender role behaviour. The lower results on cognitive measures overall 
in boys and men with proximal hypospadias warrant further studies.  
 
3.5 ETHICAL CONSIDERATIONS 
There are a number of ethical issues currently discussed in the field of DSD patient care and 
research (186). With regards to clinical care, the debate has for some time centered on the 
timing of surgery, patients right to full disclosure of information and right to make decisions 
about irreversible cosmetic surgery and hormonal treatments. Healthcare providers, 
researchers, patient organizations and government offices are attending to these questions 
attempting to produce knowledge and mapping of the healthcare issues but also to influence 
policy. In Sweden the issues concerning early surgery has been acknowledged by SMER, the 
Swedish Medical Etic advisory board (187) and other aspects of health cares approach to 
individuals with DSD as a patient group have been described by the Swedish National Board 
of Health and Welfare (188).  Attention has also been received from non profit organizations 
like Amnesty (189), particularly concerning the question of timing of surgical and other 
irreversible interventions.  
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The Council of Europe issued a paper in 2015 describing human rights of intersex people in 
Europe (190) and has recently issued a statement concerning healthcare approaches to DSD 
patients both of which has been responded to by members of the professions (191,192).  
 
Since medical healthcare in itself, with the best of intentions, has contributed to problems in 
these patient groups in the past, there is no guarantee that treatments of today are completely 
free from unexpected adverse effects. While this thesis incorporates and touches upon the 
questions concerning treatment and while the program overall includes investigations of 
sexual health and other intimate topics, the need for ethical considerations have been 
somewhat more restricted in this particular project. 
 
Efforts to make this project as efficient and non-intrusive as possible were made. First a 
screening carried out by a patient representative of our survey and study design for 
potentially negative or offensive framings of problems or questions. Second, we tried to do as 
much as possible at one visit, working multi-professionally. Third, we have provided patients 
that were not in a follow up program with medical advice and referrals (men with 
hypospadias) and psycho-education concerning the condition, if wished for (women with 
DSD and POI) and limited psychological counseling and facilitation of access to mental 
health care if needed (all patient groups). The offer to receive psychological counseling was 
not extended to controls. In hindsight this might seem regrettable, since there was a 
comparably high prevalence of psychiatric comorbidity in this group too. 
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4 DISCUSSION 
This thesis set out to investigate psychosocial, psychological and psychiatric aspects of living 
with a DSD condition and also to test theories on the biological contributions to sex 
differences in behavior and cognition.  
 
4.1 MAIN FINDINGS 
Briefly stated  
• There were suboptimal psychosocial outcomes for patients with CAH regarding 
education, ability to participate in worklife and fertility that differed depending on 
disease severity and sex.  
• Psychiatric morbidity was increased in women with CAIS, GD and POI. 
• Women with CAIS and GD perform more similar to women than men on cognitive 
tasks that usually yield sex differences. 
• There were no differences between men with hypospadias and male controls on 
cognitive tasks that usually yield sex differences or on self-reported gender role 
behavior.  
 
 
4.2 PSYCHOSOCIAL AND PSYCHIATRIC ISSUES IN THE STUDIED 
POPULATIONS  
 
Sex and severity moderate outcome 
We found that while psychosocial outcome was comparable to controls in some aspects it 
was negatively affected for men and women with CAH. This was particularly evident 
regarding education and ability to participate in work life, resulting in dependency on social 
insurance (sick leave and disability pension), and fertility was also decreased.  
The lower academic achievement particularly for the female patients with the severe type of 
the condition was one of the findings in study I. Chronic conditions in general are associated 
with poorer academic achievement (193) which has been accredited in part to the success of 
pediatric medicine in improving long term survival (194). Adolescents living with chronic 
conditions sometimes have a double disadvantage that affects academic achievement (195) 
although the reasons behind this may vary between conditions. In CAH, the treatment has to 
be managed everyday in order to optimize physical and mental capacities to cope with 
internal and external stressors, as well as maintain basic functions. This in itself can be a 
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stressor and a burden. Problems with adherence are not much studied in CAH but if present, 
may contribute to the impaired ability to cope with stressors. It is known from stress research 
that glucocorticoid deficiency, as well as overexposure, affects cognitive function (196,197). 
In CAH, higher doses have been linked to cognitive, particularly executive dysfunction (198). 
In study I however, since lower academic achievement (being less likely to be eligible for 
secondary education) was only true for girls, we did not assume that cognitive dysfunction 
was the primary reason for suboptimal outcomes. It may however contribute to a spectrum of 
risk factors. 
 
We interpreted the suboptimal academic achievement as being primarily dependent on other 
psychological factors. Indeed, in subsequent studies in the same cohort, increased psychiatric 
morbidity was found for women (162) and men (161) with CAH, where the increased risk in 
women with the more severe forms of the condition was not consistently found for men. This 
pattern corresponds to the results in Study I where women with SW were least likely to be 
eligible for secondary education.  
To have CAH increased the odds of having periods of sick leave or to receive disability 
pension indicating that capacity for full time participation in work life is reduced. This 
replicates findings from a Norwegian study (160). While the reasons for being on sick leave 
or to be entitled to disability pension in the individual case can be manifold, it is possibly 
affected by ability to cope with stress and demands of daily life.  Sick leave and disability 
pension in the Swedish social insurance system is at present two forms of allowances, 
administered by the same authority and can be seen as a continuum as one often precedes the 
other. It may be that these two outcomes reflect the same underlying vulnerability and that 
disease severity moderates the outcome where patients with more severe forms (SW) more 
often had disability pension and less severe (SV) more often were on sick leave.  
Fertility in women with CAH have previously found to be impaired (160,170,199) 
particularly for those with SW and SV form (200) whereas those with NC form have been 
reported to be normal (201). Reasons for infertility have not been sufficiently clarified but 
hypothesized to relate to factors related to hyperandrogenism, outcome of genital surgery and 
subsequent impaired sexual health and reduced motivation to become a parent (200). 
Fecundity for those who have attempted and persisted to get pregnant is also reported to be 
normal (202) which indicates that healthcare interventions make a difference for those who 
wish to conceive. 
The lower fertility in men with CAH, which was not present in men with non-classic CAH, 
has been the subject of previous and present research. Lower fecundity for men with CAH, 
despite reporting living in a relation and/or equal or higher marriage frequency, has been 
noted also in other cohorts (203) and has been hypothesized to result from both 
hyperandrogenism and also suboptimal psychosocial adaptation (204). Secondary problems 
related to CAH that have been connected to lower fertility are benign adrenal rest tumors and 
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suppression of gonadotrophin secretion. The latter may lead to hypogonadotropic 
hypogonadism resulting from under treatment and may be corrected with at least partial 
restitution of fecundity (203). Further exploration of fertility in the whole cohort of Swedish 
men with CAH comparing those born before and after newborn screening showed that older 
men have children by adoption to a higher degree than younger men who more often have 
biological children (205) indicating that improvement in disease management early in life 
makes a difference.     
 
Women with DSD conditions have more adverse outcome 
Suboptimal outcomes were present for both women and men with CAH, yet the women 
seemed to fare worse. Particularly this was true for women with the most severe genotype, i. 
e. SW form of CAH. They were married much less often than female controls and even 
though the rate of registered partnerships was increased, this did not compensate for the 
discrepancy since men were married to a larger extent than controls. Lower rates of marriage 
have been reported in groups living with chronic conditions (194) and there are also sex 
differences but in the opposite direction for individuals with growth hormone deficiency 
(206). The individual reasons for this may perhaps best be found in qualitative research based 
on interviews. One such report summed up and interpreted the challenges faced by women 
with CAH as “….a struggle for dignity, individuality and self agency on the one hand  and 
shame, on the other” (44). However, the most obvious difference between men and women 
with CAH is perhaps that while the men have a chronic condition affecting daily living, the 
women also experience the aspects of the condition associated with DSD, i. e. those affecting 
psychosexual development. This seems to constitute a somewhat more complex risk factor 
for adverse psychosocial outcome. 
In study II we found a larger prevalence of psychiatric morbidity in a group of women with 
CAIS and Gonadal dysgenesis compared to controls.  This indicates that a DSD condition or 
some factor related to it constitute a risk factor for the development of psychiatric symptoms 
in women. We hypothesized that congenital adverse hormonal situation would constitute a 
risk factor compared to acquired hormonal deficiency but found no support for this as the 
prevalence of psychiatric diagnoses did not differ between women with DSD and women 
with POI. Shared factors between women with CAIS and POI and many other women with 
DSD are that the knowledge of the condition is received during critical periods of identity 
formation (teenage years or childbearing years). Many patients describe a trauma connected 
to receiving a diagnosis and finding out about physical differences that impact fertility and 
putting one in a position that differs from peers at a point when this is crucial; not receiving 
your menses during the teenage years, or to not be able to have children when your friends 
are forming families. Previous trauma of other kinds less related to the DSD condition could 
also be present. We did not include a measurement of previous traumatic experience but 
qualitative interviews with some of the participants showed that this had an impact on the 
way the diagnosis was understood and how coping strategies were developed (43). Being part 
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of a minority might also play a role as a psychosocial stress factor. The concept of minority 
stress (207) has not yet been investigated systematically in DSD but is sometimes mentioned 
as a mediator of psychosocial outcome (208). 
Socioeconomic status was not evaluated in our studies and could impact the results. Previous 
studies in CAIS and women with other XYDSD diagnoses have however observed superior 
socioeconomic outcomes in a Danish population study where women with XYDSD had 
higher income than controls (209) and an Italian study of women with CAIS where 
educational and professional achievement were superior to that of controls (210). Other 
possible factors acknowledged as risk factors in women with DSD in general is poor outcome 
of surgical interventions (167) contributing to suboptimal sexual wellbeing and function 
(211,212), the removal of gonads, substitution with synthetic hormones and exposure to 
repeated genital examinations (169).   
Our results, indicating increased vulnerability for female patients with DSD conditions are 
not unique. Previous research has also concluded that women with DSD fare worse than men 
in terms of psychosocial adjustment. Is this a phenomenon occurring in DSD conditions only 
or are there general factors with impact? Women are in general more affected by mood 
disorders. Epidemiological studies estimate the lifetime prevalence for women to be 21.3%, 
which is almost twice that of men 12.7% (213). This sex gap emerges in adolescence and 
wanes in midlife. Both biological background factors and social background factors are 
hypothesized to contribute to this discrepancy and both include multifactorial explanations. 
Genetic vulnerability together with fluctuations in sex hormones (74) and HPA and HPG axis 
dysregulation have been discussed (75). Sex hormones, particularly progesterone and 
estradiol, are important modulators of neurotransmission that have impact on both 
serotonergic and dopaminergic pathways. These are also pathways showing sex differences 
(16). The abundance of glucocorticoid and gonadal steroid receptors in large parts of the 
brain is also an indication that sex steroids and glucocorticoids impact many transmitter 
substance systems by a variety of mechanisms (214).  
Biological vulnerability alone cannot explain these differences but may be understood as an 
important risk factor. Psychosocial aspects such as role-stress, trauma, internalizing coping 
strategies and disadvantages in social status are all acknowledged as contributing factors 
(213) to psychiatric morbidity. Many biological and social factors are accentuated and further 
complicated in women with DSD. Therefore increased vulnerability is present and may 
contribute to understanding why adult patients with DSD in some studies have shown 
psychological distress on levels comparable to women with a history of physical or sexual 
abuse (215). 
Knowing this, what can be done to prevent or ameliorate the increased prevalence of 
psychiatric morbidity? The strengthening of resilience factors, increased psychosocial support 
and changes in medical interventions are requested from lobbyists and patient advocate 
groups. There are very few studies of psychotherapeutic interventions for patient groups 
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within the DSD spectrum but recommendations based on qualitative studies (42) and some 
tailored cognitive behavioral interventions have been published (216).   
While replicating and extending results that show increased risk of adverse outcome we also 
found what seem to be some advantages. In study I, the analyses on subgroup level showed 
that women with SV CAH pursued higher education more often than controls and women 
with SW had higher income than controls. The small sample sizes on the level of sex and 
severity made it difficult to control for confounders such as having a family or not and 
socioeconomic status of original family. Despite these limitations we concluded that it might 
be factors related to the condition that contributes to this superior outcome related to 
academic achievement for women with SV CAH and income for women with SW CAH. 
Also in study III, we unexpectedly found that women with XXGD performed superior to both 
men and women on a test of emotion recognition despite not performing differently on any 
other tests of cognitive function. While refraining to interpret this finding before it has been 
replicated, there seems to be some evidence that factors related to DSD conditions can 
enhance some aspects of functioning.  
 
4.2.1 Methodological limitations 
In study I, many compromises were made when selecting parameters and planning analyses 
due to limitations in the data sources and the size of patient groups. We wanted to compare 
outcome for those identified by newborn screening to those that were discovered by clinical 
presentation to assess if screening had improved outcome. While this had been possible for 
some parameters like marriage or level of education, only sick leave and disability pension 
differed between patients and controls on the level of the whole patient group. Newborn 
screening for CAH was initiated in 1986. The register data for disability pension was 
available from 1990-2004 making this comparison impossible, as those identified by 
screening could not yet have received this form of allowance. The comparison would have 
been possible for the sick leave parameter. However, the rules and regulations for health 
insurance and labor market politics have changed the pattern of sick leave over the time 
period covered and this was judged to be an analysis that required more correction of other 
demographic and historical factors than were deemed possible given the timeframe of the 
study.  Comparison of fertility has been performed in another study with a slightly different 
selection of the group, showing improved fertility after newborn screening (205).  
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4.3  STUDIES OF COGNITION IN DSD POPULATIONS 
 
Women with XYDSD perform more similar to female than male controls 
In study III, we found that women with CAIS and GD, both with XY karyotype but minimal 
exposure to or receptivity for androgens, performed more similar to female controls on most 
cognitive tasks but not on verbal fluency and emotion recognition.  
Research in clinical populations bring a number of biases, such as small patient numbers, non 
typical variations in general intellectual performance, working memory or other cognitive 
abilities (217). Variation in results can also depend on the use of measures that do not show 
sex differences, lack of information on general intellectual ability and when cognitive 
measures are applied, on roof and ceiling effects. Previous studies of cognitive abilities in 
CAIS have struggled with all these issues and our study is one of the first that clearly show 
that women with CAIS perform more like female controls on most cognitive tasks that yield 
sex differences in the control groups. 
The lower performance by women with CAIS and GD on word fluency and emotion 
recognition, on the same level as the male control group, was contradicting the pattern of 
performing like the female controls. Word fluency is a task dependent on several cognitive 
abilities, and is mostly used in clinical practice as a measure of executive functions. However 
it is also dependent on language abilities. As some individuals in the patient group were 
nonnative, albeit fluent, Swedish speakers we found it difficult to draw conclusions based on 
this finding as it may be related to small differences in language proficiency. The results on 
the emotion recognition task were surprising. They were not in line with the previous 
published study (218) that uses the same task. In that study, emotion recognition was 
investigated in groups with variations in testosterone synthesis and sensitivity (CAH, 5α-
reductase deficiency, CAIS and male and female controls). The results showed that 
performance was associated with androgen exposure such that the group with least 
exposure/effect (CAIS) performed better than all patient groups and also better than control 
males. Female controls were superior in performance. The mean results in this study for all 
groups however, are on a much lower level than in our study, potentially indicating that the 
test has a somewhat different function in groups of different cultural and geographic 
background, which is discussed by the authors (218). The mean performances in our groups 
are also higher than in the original study and in the Swedish validation study (table 11). 
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Table 11. Reading the mind in the Eye, mean performance in studies carried out in the United Kingdom, 
Sweden and Iran. 
Revised version, Baron 
Cohen 2001  
Söderstrand et al 
2012 Swedish 
validation study 
Strandqvist et al 
2018 
Khorazad et al 
2018 
♀ General pop 26.0 
♂ General pop 26.4 
♀ Students 28.6 
♂ Students 27.3 
♀♂AS1/HFA2 21.9 
♀♂IQ matched 330.9 
♀♂ 27.2 
 
 
♀ 28.3 
♂ 26.5 
♀CAIS 26.2 
♀XYGD 24.7 
♀XXGD 31.1 
 
♀ 23.5 
♂ 21.0 
♀CAIS 22.9 
♀CAH 19.8 
♀5αRD2 18.1 
 
1 Autism spectrum group 2 High functioning autism group 3 Individuals that were IQ matched to the autism 
spectrum group. 
 
Distribution of results on the emotion recognition task 
 
Fig 4. Distribution of test results for female controls, male controls, the combined group of women with CAIS 
and XYGD and the group of women with XXGD on the reading the mind in the Eyes test.   
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The distribution of results for the different groups are spread out and the distribution of 
results for the group of women with XYDSD could match that of the group of male controls 
but it also did not differ much from that of female controls, except for a cluster of four 
individuals (fig 4).  These four individuals contribute to the lower average and if they are 
excluded the difference to female controls ceases to reach significance. The reason for the 
lower performance of these four women is not known. They are not afflicted with 
neuropsychiatric disorders, are not born abroad and do not have low vocabulary performance. 
Assuming the results are not due to motivational issues or chance findings, this indicates that 
factors related more directly to sex chromosome disposition may be important for 
performance on emotion recognition tasks. Further research is warranted. 
While androgens have been shown to enhance spatial ability, less is known about what 
explains variation in abilities where women typically excel. We found that women with XX 
GD outperformed all other groups on the emotion recognition task. Unless this is a chance 
finding or the result of some other shared factor between the women we may assume that the 
optimal prerequisites for development of superior emotion recognition skills is related to XX 
chromosomes and low pre and postnatal exposure to sex steroids but may also be related to 
the timing of puberty, which has been suggested to impact ability to read emotion in faces 
(219). As the group of XXGD consists of only seven women, significantly younger with a 
higher education level than controls and other patient groups, the reason behind this superior 
performance need replication in a larger group before conclusions can be drawn.  
The impact of oral contraceptives (OC) on brain function and mood is a growing field of 
research. OC use have been previously associated with both increased attention, enhanced 
and impaired function in experimental studies of perception of emotional faces as well as 
unaltered performance for emotion recognition (220). Whether long term OC use can affect 
cognition performance needs to be taken into account in future studies of cognition in DSD 
patients.   
 
Men with hypospadias perform similar to male controls 
There were to our knowledge, no prior studies on cognitive functions or profiles in men with 
hypospadias and there is also a lack of studies on psychosexual outcome (142). The results 
from cognitive tests and surveys in our cohort of men with hypospadias showed no 
association between the condition and self-reported gender role behavior or cognitive 
functions. This implies that whether or not there are differences between the groups in terms 
of early hormonal exposure/ situation, or genetic effects that impact genital growth and 
formation, these possible differences have no or negligible effect on gender typical behavior 
or cognitive function in a group of men with mixed background reasons for hypospadias. To 
be able to reason around the impact of androgen exposure or receptivity per se, the selection 
of men with hypospadias would have to be restricted to a group where known dysfunction of 
androgen synthesis or receptivity was present. The results from the small group of men with 
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proximal hypospadias showing lower cognitive performance may be an indication of 
comorbidity affecting cognitive function for individuals within the group and may contribute 
to understanding of the adverse psychosocial outcome seen within this group in other studies 
(67).  
 
A reflection on socialization 
In our studies the social impact during development was not assessed but we assume that the 
social impact in terms of growing up in a female or male gender role is approximately the 
same for women with DSD and men with hypospadias as for female and male controls 
respectively, recruited from the general population. One aspect of socialization is that it is 
dependent on the environment. The individual however, by seeking out and following his or 
her own preferences, participate in selecting and perhaps co-creating that environment. 
Therefore, biological effects that impact preferences can indirectly shape environment, 
interacting with opportunities and create training effects. For women with CAH it has been 
shown that they have better geographical knowledge and knowledge of how mechanical tools 
are used, skills that are learned by training rather than being innate (122). That early exposure 
to sex hormones would in fact have an effect on preferences rather than innate ability, leading 
to increased activity that may lead to better achievement on some tasks, is put forth by some 
as an important explaining factor for the variance in sex differences (221).  
 
Critical periods for brain sex differentiation induced by hormonal exposure 
Androgens play a crucial role for prenatal genital development, and the brain is also 
influenced by the fluctuations in sex hormone levels but while genital development has a 
sensitive window during the first half of gestation, the entire period from before birth to 
around puberty has been suggested to constitute a sensitive period for brain development 
(22). Most research done hitherto on critical periods was carried out in animals and the 
evidence in humans for sensitive/critical periods either regarding gender role behavior, 
gender identity or sexual preferences is scarce and understudied.  
Previous research in girls and women with CAH, together with twin studies (222) show 
support for organizing effects of prenatal androgen exposure. Girls with CAH receive 
treatment from birth and onward, with the aim of correcting the cortisol deficiency and 
lowering androgens. Therefore, given that treatment is initiated and adherence is good, they 
do not have elevated postnatal androgen exposure. This is in contrast to boys that typically 
experience a postnatal surge of testosterone, which could contribute to the predisposition to 
develop superior skills in mental rotation.  
Studies in girls and boys from the general population have shown the significance of 
postnatal exposure, by relating testosterone levels pre and postnatal to play behavior in 
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toddlers, controlling for prenatal exposure and postnatal growth (223-225). During puberty, 
somatic effects of sex steroids are evident like deepening of the voice and general growth. 
Whether there are organizational effects of sex steroids on brain and behavior during puberty 
is debated. Some studies show changes of brain anatomy and function associated to androgen 
levels during puberty at least for boys (28,226) while previous studies fail to show any 
change in sex differences pre and post puberty (227). There is also evidence of negative 
effects of androgen levels on spatial behavior following puberty, favoring a different 
hypothesis that state late pubertal maturation as important for good spatial abilities (228).  
 
Sex chromosomes 
Experimental animal research shows a clear case for sex chromosome complement and/or sex 
specific gene expression to sometimes modulate, sometimes enhance or act together with 
hormone exposure to increase or decrease sex differences. In human studies, the evidence is 
not yet substantial enough to conclude a significant effect of sex chromosome complement on 
either cognitive or behavioral development. There are however circumstances in some of the 
DSD conditions natural history that indicates that karyotype makes a difference. One 
example is that gender identity development in individuals with 46,XY and partial androgen 
insensitivity or a defect of synthesis, is often in the male direction, given some androgen 
effect. However the paradigm change that has emerged, directing focus on the uniform effect 
of these two aspects, hormones and karyotype, acting in concert driving and directing sex 
differentiation together with the environment will direct future research and have clinical 
implications for DSD healthcare. 
 
4.3.1 Methodological considerations 
Translating research from animal studies 
Experimental research in animals has built the theoretical framework, conceived and tested 
the main hypotheses and continue to expand knowledge concerning sex differentiation. In 
translating these findings to humans there are however serious limitations. For one, biological 
mechanisms of sex differentiation differ between species. Masculinization of rodent behavior 
is induced by the aromatization of estradiol into testosterone whereas in primates and 
presumably in humans, testosterone and dihydrotestosterone induce defeminisation and 
masculinization (11). An illustration of this difference is knockout mice with CAIS that are 
masculine in their behavior, which devaluates comparison with humans in both sickness and 
health.  Besides this, one of the most important aspects of psychosexual development, namely 
gender identity, is not possible to observe in animals. Therefore, to know how these effects 
present in humans, given our complex social environment and in many aspects shown 
plasticity of brain anatomy, we have to refrain from drawing conclusions before relevant 
studies have been made.  
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The limitations of the model disorder paradigm  
The social environment, personal experiences and inborn predispositions interact for 
psychosexual and cognitive development on an individual level. On a group level however, 
both biological and environmental influences can be studied given that one can tease apart the 
influence of one on the other to some extent. DSD conditions are sometimes referred to as 
“model disorders” to study the impact of the biological contributions while keeping constant 
the impact of gender socialization. This model of studying is not without flaws but it is one of 
very few ways of gaining knowledge on a hard to reach and important subject. One of the 
issues with this approach is that other effects of the conditions may constitute bias in the 
investigation. In studies on CAH and cognition this has become increasingly evident as 
working memory (118,229) and executive dysfunctions have been documented, possibly 
affecting outcome in other cognitive measures as well.  
Another limitation relates to the possibility to assess the biological parameters on which 
assumptions are made in studies investigating prenatal influences on brain development. 
Many parameters like levels of prenatal exposure to testosterone are not possible to observe 
or measure directly. When investigating this in girls with CAH we infer the elevated 
androgen exposure during gestation as revealed by the level of masculinization of genitalia 
that takes place during the first trimester of gestation or by known CYP21A2 genotype. It is 
generally assumed that the levels of androgens for girls with CAH are somewhat higher than 
that of typically developing boys and also constant, instead of showing the first trimester 
peak, present in typically developing boys. The activity of other enzymatic pathways leading 
to increased production of DHT may also be of importance (230). 
In addition it is not known how the body, placenta and other tissues compensates, adapts or 
fails to adapt to this hormonal situation. To add to this, the sensitivity of the androgen 
receptor is a factor that is difficult to evaluate in the clinical and research situation. Therefore, 
in studies observing the association between for example early androgen exposure and three-
dimensional mental rotation the outcome is being studied while the exposure is only 
estimated. 
In our studies, similar limitations are present. In study II for example, we do not know the 
cause of ovarian dysfunction in women with POI and can therefore not be certain that they 
had not had some difference in sex hormone stimulation or response earlier or that their 
hormonal situation is due to another factor, also contributing to the susceptibility to 
psychiatric morbidity. Autoimmune reactions with increased inflammatory responses are 
possible alternative biological explanations to the increase in psychiatric symptomatology. In 
addition we also could not control for previous or present use of hormonal substitution, as we 
did not have full retrospective information of this.  
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Hence, different mechanisms may congregate in the study of clinical conditions. There are 
possible psychosocial confounding factors unevenly distributed between the groups like 
possible gender identity issues, trauma of receiving diagnosis at different ages and unresolved 
fertility issues. To better account for these differences and comparisons, some measure of 
perceived trauma may have improved the background demographic descriptions and 
contributed to better understanding of psychiatric morbidity in study II. 
4.4 CLINICAL IMPLICATIONS 
Need of psychological interventions in routine healthcare for DSD populations 
Psychosocial outcome for DSD patients is often compromised and we know that information, 
counselling and support is helpful both as prevention and to overcome difficulties (231). The 
suboptimal outcomes for women with CAH in study I indicate that as a group, they have 
needs for psychological interventions tailored to their situation, general and individual needs. 
While it may be appropriate at many times while growing up it is especially urgent for 
adolescent and young adults facing challenges in everyday life in the educational situation, in 
developing a healthy body image, sexual identity as well as a personal identity overall.  The 
high prevalence of psychiatric comorbidity in study II indicates that women with CAIS and 
gonadal dysgenesis should be screened at some point for psychiatric symptoms and offered 
psychosocial support. From previous literature it seems urgent when the diagnosis is new as 
this may constitute a trauma in itself but one clinical experience from this project is that the 
trauma can also be re experienced at a later point when issues around fertility or forming of 
stable relationships emerge at stages of life when this becomes important, for example during 
childbearing age. 
While genital malformations can be the primary source of psychological burden, it is 
essential not to overlook other issues like body image and other attitudes and perceptions 
about the condition. The impact this may have on self-esteem, feeling different and also the 
potential trauma from healthcare experiences may constitute a problem in different situations 
in life. In DSD, the surgical interventions have been standard whereas psychological support 
and screening for cognitive and other developmental problems have been optional and more 
difficult to get access to (231). Despite recommendations, not all centers offer psychological 
support. This is regrettable as the potential risks with psychological interventions are 
negligible compared to other alternatives. 
The results in this thesis support the claims made from patients and caregivers alike to 
increase psychological support in care for DSD populations and to include screening for 
psychiatric symptoms in the care for women with DSD, neurodevelopmental problems in 
boys with proximal hypospadias and perhaps also screening for both cognitive deficits and 
psychiatric symptoms in women with severe forms of CAH. 
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Cognitive abilities are not impaired in women with CAIS and GD 
The results of study III that women with CAIS and GD perform like female controls further 
corroborates previous research that shows predominantly female psychosexual development 
in women with CAIS. The slightly lower result on word fluency and emotion recognition is 
not necessarily indicating impaired performance as it is on the level of the mean performance 
in the general population in studies from other countries.   
 
Hypospadias in general, is not associated to variation in cognitive abilities and gender role 
behaviour  
The clinical implication of study IV is information to clinicians and parents of children with 
hypospadias concerning questions around psychosexual development and cognitive 
development. There is no reason to believe that mild hypospadias is associated with 
variations in development to a larger degree than in the general population. 
 
4.5 FUTURE PERSPECTIVES 
To further the knowledge of risk factors for negative psychosocial and psychiatric outcome 
In study I and II we found compromised psychosocial outcome and increased psychiatric 
morbidity for the patient groups under study. The vulnerability to psychiatric disease point to 
serious side effects of the disorders but we do not know enough about the risk and resilience 
factors in development of psychiatric comorbidities, or the relative contribution of the known 
risk factors. Researchers in DSD and related fields have emphasized the importance of the 
factors that mediate and moderate psychosocial outcome rather than to have a narrow focus 
on psychosexual aspects of DSD or the outcomes per se (232) since the mediators highlights 
and directs needs for psychological intervention as well as preventive measures.  
To further knowledge of outcome on rare disorders, transnational and international 
cooperation is a possibility to assess the same parameters in groups large enough to reach 
sufficient statistical power. DSD life is one such endeavor (233) and perhaps the future will 
see more such joint projects between different clinics/research groups. 
 
The mediating aspects of psychosocial outcome in women and men with CAH  
Many of the results in study I could be elaborated further like whether the periods of sick 
leave for patients with CAH that to some extent depend on disease severity is also associated 
to mental health status. That women with CAH to a larger extent do not have complete basic 
education at the appropriate age is worrying and needs further clarification. Are the reasons 
for this found in aspects of functioning related to mental health, executive or intellectual 
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capacities, adherence to treatment, psychosocial environment like bullying, loneliness or is it 
a side effect of going through secondary surgery at the age when you are also finishing 
school? For women with CAH, overtreatment with glucocorticoids is sometimes suggested as 
a cause of negative side effects of treatment. As girls risk masculinizing effects of cortisol 
deficiency and this is not as feared in boys, girls may receive slightly higher doses of 
hydrocortisone as a preventive intervention, but to what extent this is related to various 
outcomes has not been studied. There is also emerging evidence of sex dimorphic effects of 
glucocorticoids (234), and genetic functions (235) that in the future may be further clarified. 
Adolescence is a period when adherence to treatment is more dependent on the person him or 
her self rather than on parents, managing the daily administration of medication. For some 
individuals, this may be a difficult task, particularly in the prescence of other problems like 
executive functions. 
It would be of great value to better understand the reasons behind school underachievement 
and absence from work life in order to better tailor treatment and support so that this chronic 
condition has least possible impact on daily life. Likewise, the results of greater variation in 
cognitive outcome for men with proximal hypospadias should be further investigated. We 
detected lower cognitive performance that may harmonize with findings of increased risk of 
adverse psychosocial outcome in men with proximal hypospadias (236).  
 
Interaction and training effects on cognitive sex differences 
The relative importance of biological and social factors is difficult to evaluate and cannot 
easily be teased apart as they as they act in concert in the emergence of sex differences. In 
stark contrast to this symbiosis stands the different research fields investigating and 
sometimes debating the importance of nature vs nurture (237).  Present models of sex 
differentiation capture these interactional processes (181) although few studies to date take 
into account interactional effects and more empirical evidence is needed. Training effects and 
other ways of capturing both aspects under different hormonal and chromosomal 
circumstances, is one of the future directions in sex difference research. 
 
The association of androgen insensitivity to cognitive abilities in men with hypospadias 
In study IV the men with hypospadias had different and sometimes unknown background to 
the hypospadias and we cannot therefore draw any conclusions from this study related to 
theories of sex steroid impact on cognition. Including men with hypospadias with an etiology 
of defects of androgen synthesis or receptivity could bring further light to this question. The 
results of gender role behavior should also be replicated in a group of boys with hypospadias 
using direct observational methods. 
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To further the knowledge on what contributes to enhanced cognitive abilities in women 
The findings of enhanced emotion recognition in women with 46, XXGD should be further 
studied and may reveal possible mechanisms behind variation in social cognitive skills where 
women outperform men.  
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5 SVENSK SAMMANFATTNING 
Bakgrund: Atypisk eller annorlunda könsutveckling (disorders of sex development, DSD) är 
benämningen på ett spektrum av tillstånd där en individs könskörtlar (äggstockar, testiklar) är 
annorlunda eller hens kromosomala, anatomiska eller hormonella situation skiljer sig från det 
typiska. Diagnoser inom denna grupp varierar vad gäller risk för somatisk sjuklighet från 
komplett benigna till livshotande och många tillstånd påverkar möjligheterna till fertilitet. 
Sjukvårdens insatser har varierat historiskt sett och har under modern tid praktiserat metoder 
som kritiserats av såväl patientorganisationer som samhälleliga instanser för att vara i strid 
mot mänskliga rättigheter. Det gäller främst kirurgi i nyföddhetsperioden men även andra 
behandlingsalternativ som medför icke reversibla somatiska och psykologiska effekter. 
Överväganden som i vissa länder görs av föräldrarna och i andra länder av medicinsk expertis 
i samråd med föräldrar kan vara både komplexa och medföra svåra etiska ställningstaganden. 
Nutida riktlinjer föreskriver multidisciplinärt omhändertagande, betonar vikten av att få 
fullständig information om sitt tillstånd och innefattar en målsättning om optimering av 
individens psykiska och fysiska hälsa och samtidig minimering av medicinska interventioner. 
Frågeställningar kvarstår kring optimal tidpunkt för interventioner.  Forskning kring utfall 
visar på suboptimala kirurgiska resultat, överrepresentation av psykisk ohälsa med en stor 
variation inom och mellan patientgrupper. 
 
Den klassiska modellen för biologisk könsdifferentiering betonar könskörtlarnas roll, dvs 
äggstockarnas eller testiklarnas, och påföljande hormon exponering för utvecklingen i manlig 
eller kvinnlig riktning. Könshormon som androgener och östrogener har under kritiska 
perioder i livet; pre och postnatalt, under pubertet, graviditet och vid menopaus effekter på 
framför allt fysisk utveckling men även andra beteenden, bland annat de som uppvisar 
könsskillnader. Även könskromosomuppsättning har i djurstudier visat sig ha betydelse för 
uppkomsten av könsskillnader då närvaro/frånvaro av genetiskt material föregår eller bidrar 
till könsdifferentiering. 
 
Dessa biologiska faktorer ger sammantaget upphov till fysiska könsskillnader men bidrar 
även till skillnader i preferenser och beteenden, kognitiva funktioner och könsrollsbeteende. 
Vilka mekanismer som ligger bakom, och hur stor inverkan de har är svårt att undersöka då 
socialiseringsprocesser interagerar och påverkar könsskillnader i hög utsträckning. Genom att 
inkludera individer med variation i könsutvecklingen med avseende på karyotyp och 
hormonell situation kan detta studeras till viss del.  
 
Syfte: Dessa studier kartlägger psykosocialt utfall och förekomst av psykiatrisk morbiditet för 
grupper av patienter med variationer i könsutvecklingen; kvinnor med CAH, CAIS, GD, POI 
och män med Hypospadi. Den belyser även frågor kring betydelsen av hormonell och 
kromosomal/genetisk påverkan för utvecklingen av könsskillnader i kognitiva förmågor och 
könsrollsbeteende. 
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Studie I 
I denna registerstudie undersökte vi psykosocialt utfall för män och kvinnor med kongenital 
binjurebarkshyperplasi, CAH med avseende på utbildningsnivå, inkomst, utnyttjande av 
sjukförsäkringssystemet, giftermål och fertilitet.  
Metod: Informationen inhämtades från flera svenska nationella register och patienterna 
matchades och jämfördes med 100 kontroller per person från befolkningsregistret.  
Analyserna gjordes både på gruppen som helhet men uppdelningar gjordes även med 
avseende på svårighetsgrad (SW, SV, NC) och mellan kvinnor och män. 
Resultat: Sammantaget visade resultaten att gruppen individer med CAH var heterogen 
beroende på svårighetsgrad av CAH och det fanns könsskillnader. Både kvinnor och män 
erhöll sjukersättning eller förtidspension oftare och hade mer sällan barn än kontroller. 
Kvinnor saknade i högre utsträckning behörighet till gymnasiet och var mer sällan gifta. Män 
var oftare fast anställda och gifta i högre utsträckning än kontroller. Kvinnor med SW hade 
oftare inte behörighet till gymnasiet men hade också oftare inkomst i övre kvintilen jämfört 
med kvinnliga kontroller. 
 
Studie II 
I den här tvärsnittsstudien undersöktes förekomst av psykiatrisk sjuklighet hos en grupp 
kvinnor med komplett androgenokänslighetssyndrom (CAIS), eller komplett gonaddysgenesi 
(GD) och jämfördes med friska åldersmatchade kontroller från normalbefolkningen samt en 
grupp kvinnor med prematur ovarial svikt (POI). Kvinnorna intervjuades med en klinisk 
strukturerad intervju, MINI-IV och fick besvara kompletterande frågor via en enkät.  
Resultat: Kvinnor med CAIS och GD hade mer psykiatrisk sjuklighet än kontroller men inte 
signifikant mer än kvinnor med POI. Det fanns en ökad förekomst av psykiatrisk sjuklighet i 
alla patientgrupper främst vad gäller ångest och nedstämdhet.   
 
Slutsatser studie I och II: Patientgrupper med DSD har en ökad risk för suboptimalt 
psykosocialt och psykiatriskt utfall vilket betyder att psykologiskt stöd bör vara en del av den 
ordinarie vården och den bör innefatta screening för psykiatrisk problematik. Orsaker bakom 
suboptimalt psykosocialt utfall behöver identifieras för att förbättra medicinskt och 
psykologiskt omhändertagande vid CAH.  
 
Studie III 
I den här studien undersöktes betydelsen av karyotyp och hormonell situation för kognitiva 
förmågor hos kvinnor med DSD med syftet att undersöka skillnader mellan grupper med XY 
karyotyp med låg och hög androgenexponering samt att jämföra kvinnor med XY resp XX 
kromosomuppsättning för att resonera kring betydelsen av hormonexponering och karyotyp.   
Metod: Kognitiva tester som i andra studier uppvisar könsskillnader; spatialt tänkande, 
verbalt flöde, ansiktsminne och emotionsigenkänning administrerades till en grupp kvinnor 
med CAIS och XYGD samt en mindre grupp kvinnor med XXGD och en grupp 
åldersmatchade kvinnliga och manliga kontroller.  
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Resultat: Kvinnor med CAIS och XYGD presterade mer likt kvinnliga än manliga kontroller 
på tester som traditionellt visar könsskillnader. På tester av igenkänning av emotioner 
presterade kvinnor med XY kromosomer mer likt den manliga kontrollgruppen medan 
kvinnor med XXGD överpresterade gentemot alla övriga grupper.  
Slutsats: Resultaten ger stöd för teorier rörande betydelsen av exponering för androgener för 
könstypisk påverkan på kognitiva funktioner medan det i vissa fall som vid 
emotionsigenkänning finns indikation för att könskromosomuppsättning eller till denna 
relaterade faktorer har betydelse. 
 
Studie IV 
I denna studie undersöktes kognitiv prestation hos män med hypospadi. Hypospadi är en 
relativt vanlig genital missbildning som drabbar en av 125 män årligen. Manlig genital 
utveckling är i vissa faser beroende av normal androgenfunktion. Därför har frågan om 
huruvida hypospadi kan förknippas med ökad variation i könsrollsbeteende och andra 
aspekter ställts.   
Metod: Män med hypospadi genomförde samma batteri av kognitiva tester som i studie III 
och en retroaktiv självskattning av könsrollsbeteende i barndomen, och jämfördes med 
kvinnliga och manliga kontroller.  
Resultat: Män med hypospadi skiljer sig inte från manliga kontroller vad gäller kognitiva 
tester eller självskattat retrospektivt könsrollsbeteende. De skiljer sig däremot från kvinnliga 
kontroller i samma utsträckning som män i kontrollgruppen. Jämförelser mellan män med 
olika svårighetsgrad indikerar att män med proximal hypospadi presterar något lägre generellt 
på kognitiva tester men skattar könsrollsbeteende likt övriga män med hypospadi och manliga 
kontroller. 
Slutsats: Faktorer som bidrar till hypospadi påverkar inte i mätbar utsträckning kognition 
eller könsrollsbeteende. Kognitiva förmågor hos män med proximal hypospadi bör kartläggas 
vidare. 
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